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Osteoarthritis (OA) is a frequent condition in the elderly population and it is 
estimated that more than 300 million people worldwide suffer from OA. The 
dominant symptom of OA is pain, but the mechanisms and pathophysiology of OA 
pain are not fully understood. End-stage knee OA is often treated surgically with a 
total knee arthroplasty (TKA), but approximately 20% of patients undergoing knee-
joint replacement will experience chronic pain following their surgery. The 
progression towards chronic pain is thought to involve a mix of local pathological 
processes in and around the knee joint, genetic and metabolic factors, and neuronal 
changes at several levels, including peripheral and/or central sensitization, and 
reduced descending inhibition. Numerous clinical guidelines and systematic reviews 
have highlighted physical activity, exercise, and education as first-line treatments for 
knee OA. For patients with chronic pain after TKA, no clinical guidelines or 
standardized treatment regimens exist and no clear treatment recommendations are 
available. 
The overall aims of this PhD thesis were to develop a clinically applicable, bed-side 
test as a useful tool to examine conditioned pain modulation (CPM) (study I), to 
profile and compare pain, pain sensitization, the patient-reported questionnaire Knee 
injury and Osteoarthritis Outcome Score (KOOS) and physical performances in 
patients with chronic pain after knee OA or TKA (study II). Furthermore, it aimed to 
investigate the benefits of an intensive, multimodal rehabilitation following primary 
or revision TKA (study III). Lastly, it set out to design and initiate an intervention 
study that would improve pain, pain sensitization, and physical performances in 
patients with chronic pain after TKA (study IV). 
Study I was a cross-sectional test-retest reliability study that included two populations 
of healthy, pain-free subjects (n= 22 and n= 29). Conditioned pain modulation was 
measured using a newly developed spring-based 6 kg pressure algometer as a test 
stimulus and a standard clamp, which induced pressure of 1.3 kg, as a conditioning 
stimulus. The test stimulus was applied to the tibialis anterior muscle belly at the 
dominant leg and the conditioning stimulus was applied to the ipsilateral ear lobe. 
The test stimulus was applied for 10 sec and the conditioning stimulus for 60 sec. 
Pain intensity ratings of the test and conditioning stimulus were made using a 
numerical rating scale (NRS) from 0-10 (with “0” representing “no pain” and “10” 
representing “worst pain imaginable”). To conduct the test-retest part, the second 
CPM test session was repeated 24-48 hours following the first test session. The 
results observed a “good” relative reliability (intra-class correlation; 0.67 and 0.72) 
for the test stimuli, although the absolute reliability indicated substantial intra-
individual variation (standard error of measurement; NRS 1.9 and 2.1). No averaged 
CPM effect was observed in the healthy subjects, and in the population, a substantial 
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variation in CPM effect was observed with both CPM responders and non-responders 
(study I). 
Study II was a cross-sectional study that included a population of 70 patients with 
chronic pain from knee OA (n= 46) and chronic pain after TKA (n= 24). Patients 
underwent a one-session assessment of pain intensity, pain sensitization parameters 
including mechanical pinprick pain sensitivity, temporal summation of pain and 
CPM, the KOOS questionnaire, and physical performances tests including the 30-
second chair stand test, the 40-meter fast-paced walk test, and the stair climb test. 
The analysis was adjusted for body mass index. The adjusted results indicated that 
similar profiles for pain, pain sensitization, CPM, and KOOS were observed for the 
OA and the TKA populations. Between-group differences for the 30-second chair 
stand test (11.2 vs. 9.7 repetitions, p= 0.015), the 40-meter fast-paced walk test (29.3 
vs. 31.8 seconds, p= 0.081), and the stair climb test (11 vs. 14.2 seconds, p= 0.002) 
were observed, with the OA group consistently performing better physically. Of note, 
a substantial variation in the CPM effect was seen in both CPM responders and non-
responders in the OA and the TKA groups (study II). 
Study III was a retrospective study, which included a population of 217 patients with 
primary (n= 166) or revision TKA (n= 51), who had experienced post-surgical 
complications, for example, persistent pain or continued functional impairments. The 
patients received three weeks of intensive, multimodal rehabilitation consisting of 
various exercise sessions to promote neuromuscular function, muscle strength, and 
cardiovascular capacity. Physiotherapists supervised all the rehabilitation activities 
and provided group-based educational sessions. As the primary outcome, the KOOS 
subscales of pain, symptoms, activities of daily living, and knee-related quality of 
life were assessed. Furthermore, pain intensities at rest and during activity and 
physical performances in terms of the 6 min. walking test and the stair-climbing test 
were evaluated. Overall, the results showed significant improvements in the KOOS 
subscales, pain intensities, and the physical performances for both groups following 
three weeks of intensive, multimodal rehabilitation. For the KOOS subscales of pain, 
symptoms, activities of daily living, and knee-related quality of life, the primary TKA 
group showed improvements of 9.8 points (p < 0.000), 9.4 points (p < 0.000), 14.2 
points (p < 0.000), and 8.5 points (p < 0.000), respectively. For the revision TKA 
group, the same KOOS subscales showed improvements of 6.9 points (p = 0.005), 
8.2 points (p < 0.000), 10.8 points (p < 0.000), and 8.6 points (p = 0.001), respectively 
(study III). 
In summary, chronic pain reported by patients suffering from knee OA or following 
TKA influences pain sensitization, CPM, patient-reported outcomes, and physical 
performances to different extents. Overall, substantial individual variations were 
observed for the investigated outcomes, which may indicate the heterogeneity of the 
chronic pain populations. Exercise appears to improve pain, patient-reported 
function, and physical performances in a TKA population with post-surgical 
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complications, and future studies should investigate whether this observation can be 
verified in a population of patients with chronic pain after TKA. Study IV was 
initiated based on this lack of high-quality evidence regarding patients with chronic 
pain after TKA. Based on the findings in this thesis, some suggestions can be made 
regarding the clinical implications. Firstly, when undertaking future CPM studies, 
authors should report individual CPM effects and observations of CPM responders 
and non-responders. Secondly, it is proposed that the studies ensure that a thorough, 
multifactorial assessment, including a matrix of pain and sensitization outcomes, self-
reported outcomes, and measures of physical performances, is undertaken for patients 
with chronic pain because of knee OA or after TKA. Such an approach would indicate 
which parameters require attention in the management of the individual patient’s 
chronic pain condition. 
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DANSK RESUME 
Slidgigt er en hyppig lidelse i den ældre del af befolkningen, og det anslås at mere 
end 300 millioner mennesker på verdensplan lider af slidgigt. Det dominerende 
symptom ved slidgigt smerter, men mekanismerne og fysiologien bag slidgigt 
smerterne er ikke fuldt ud klarlagt. Svær slidgigt i knæet behandles ofte kirurgisk 
med indsættelse af en total knæ-alloplastik (TKA), men ca. 20% af patienterne, som 
gennemgår denne operation, vil opleve kroniske smerter efterfølgende. Det antages 
at progressionen mod kronisk smerte involverer en blanding af lokale patologiske 
processer i og omkring leddene, genetiske og metaboliske faktorer og neurale 
ændringer, herunder perifer og/eller central sensibilisering samt nedsat evne til at 
sende smertehæmmende signaler. Talrige kliniske retningslinjer og systematiske 
litteraturgennemgange har fremhævet træning og patientuddannelse som primær 
behandling af slidgigt i knæet. For patienter med kroniske smerter efter TKA findes 
der ingen kliniske retningslinjer eller standardiserede behandlingsregimer, og derfor 
eksisterer ingen klare anbefalinger ift. behandling af denne patientgruppe. 
Det overordnede formål med denne Ph.d. afhandling var at udvikle en klinisk 
anvendelig test til undersøgelse af smertemodulation (conditioned pain modulation, 
CPM) (studie I), udføre profilering af og sammenligne smerteintensitet, 
sensibilisering, spørgeskemaet Knee injury and Osteoarthritis Outcome Score 
(KOOS) og fysisk formåen hos patienter med kroniske smerter efter slidgigt i knæet 
eller efter TKA (studie II) samt at undersøge virkningen af intensiv, multimodal 
genoptræning efter primær eller revisions TKA (studie III). Derudover at designe og 
igangsætte et randomiseret interventionsstudie, som har til formål at mindske 
smerterne, mindske sensibilisering og forbedre fysisk kapacitet hos patienter med 
kroniske smerter efter TKA (studie IV). 
Studie I var et tværsnitsdesign som undersøgte test-retest reliabiliteten af et 
nyudviklet tryk-algometer. Forsøgsdeltagerne var raske, smertefri forsøgspersoner (n 
= 22 og n = 29). Smertemodulation blev målt ved hjælp af et fjederbaseret 6 kg tryk-
algometer som test stimuli og en standard klemme, som klemte med et tryk på 1,3 
kg, som konditionerings stimuli. Test stimuli blev påført på muskelbugen af tibialis 
anterior på det dominante ben, og konditionerings stimuli blev påført på øreflippen 
på modsat side af det dominante ben. Test stimuli blev påført i 10 sekunder og 
konditionerings stimuli i 60 sekunder. 
Smerteintensiteten af test og konditionerings stimuli blev vurderet på en numerisk 
rangskala (NRS) fra 0-10 (hvor "0" repræsenterede "ingen smerte" og "10" 
repræsenterede "den værste tænkelige smerte”). Dette setup blev gentaget 24-48 
timer efter den første test session for at kunne vurdere test-retest reliabiliteten. 
Resultaterne viste, at den relative reliabilitet kunne betragtes som værende ”god” 
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(intra-class correlation; 0,67 og 0,72) for test stimuli, hvorimod den absolutte 
reliabilitet viste at der var stor individuel variation (standard error of measurement; 
NRS 1.9 og 2.1). Studiet registrerede ingen CPM effekt på gruppeniveau hos de raske 
forsøgspersoner, og der blev observeret stor variation i CPM effekt (study I). 
Studie II var et tværsnitsstudie, der omfattede en gruppe af 70 patienter med kroniske 
smerter som følge af enten slidgigt in knæet (n = 46) eller efter TKA (n = 24). 
Patienterne gennemgik en enkelt undersøgelsessession, hvor de fik vurderet deres 
smerteintensitet, sensibilisering, herunder smerte følsomhed og temporal summation, 
CPM, KOOS spørgeskemaet og deres fysiske kapacitet, hvilket inkluderede en 30 
sekunders rejse-sætte sig test, en 40 meter gangtest, og en trappe test. Under den 
statistiske analyse blev resultaterne justeret for body mass index. De justerede 
resultater viste, at profilerne for smerteintensitet, sensibilisering, CPM og KOOS var 
sammenlignelige for gruppen med slidgigt i knæet og gruppen med TKA. Derimod 
var der forskel mellem grupperne for 30 sekunders rejse-sætte sig testen (11,2 vs 9,7 
gentagelser, p = 0,015), 40 meter gangtesten (29,3 mod 31,8 sekunder, p = 0,081) og 
trappe testen (11 vs. 14,2 sekunder, p = 0,002), hvor gruppen med slidgigt præsterede 
de bedste resultater. Vedrørende CPM målingerne blev set en stor variation i CPM 
effekt hos begge grupper (study II). 
Studie III var en retrospektiv undersøgelse, der omfattede en gruppe på 217 patienter 
med primær (n = 166) eller revisions TKA (n = 51), som havde oplevet 
komplikationer efter operationen, f.eks. vedvarende smerter eller nedsat fysisk 
formåen. Patienterne modtog tre ugers intensiv, multimodal genoptræning bestående 
af forskellige træningssessioner. Formålet var at forbedre neuromuskulær funktion, 
muskelstyrke og kredsløbs kapacitet. Alle træningssessioner var superviseret af 
fysioterapeuter og disse stod også for gruppebaseret patientuddannelse. Det primære 
effektmål var KOOS domænerne smerter, symptomer, funktion i dagligdagen og 
knæ-relateret livskvalitet. Desuden fik patienterne vurderet deres smerteintensitet i 
hvile og ved fysisk aktivitet og deres fysiske kapacitet i form af en 6 min. gangtest 
og en trappe test. Overordnet set viste resultaterne signifikante forbedringer i KOOS 
domænerne, smerteintensiteterne og den fysiske formåen efter tre ugers intensiv, 
multimodal genoptræning. For KOOS domænerne smerte, symptomer, funktion i 
dagligdagen og knæ-relateret livskvalitet viste gruppen med primær TKA 
forbedringer på henholdsvis 9,8 point (p <0,000), 9,4 point (p <0,000), 14,2 point (p 
<0,000) og 8,5 point (p <0,000). Gruppen med revisions TKA viste på de samme 
KOOS domæner forbedringer på henholdsvis 6,9 point (p = 0,005), 8,2 point (p 
<0,000), 10,8 point (p <0,000) og 8,6 point (p = 0,001) (study III). 
Kroniske smerter som følge af slidgigt i knæet eller efter TKA har indflydelse på 
sensibilisering, CPM, patientens subjektive oplevelse af smerterne og den fysiske 
kapacitet. Samlet set blev der observeret stor individuel variation for de undersøgte 
effektmål, hvilket kan indikere heterogenitet hos patientgrupperne med kroniske 
smerter. Træning ser ud til at kunne forbedre smerterne, den selv-rapporterede 
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funktion og fysisk kapacitet i en gruppe af patienter med komplikationer efter TKA, 
og fremtidige undersøgelser bør undersøge, om denne observation kan verificeres i 
en population af patienter med kroniske smerter efter TKA. Studie IV blev igangsat 
på grund af den manglende evidens med hensyn til effektiv behandling af patienter 
med kroniske smerter efter TKA. Ud fra resultaterne i denne Ph.d. afhandling kan der 
foreslås nogle kliniske implikationer. For det første bør forfatterne rapportere 
individuel CPM effekt og ikke kun CPM effekt på gruppe-niveau, når der 
gennemføres fremtidige CPM undersøgelser. For det andet anbefales det at foretage 
en grundig vurdering af de multifaktorielle årsager, som kan have indflydelse på 
patienternes kroniske smerter på grund af slidgigt i knæet eller efter TKA. Dette vil 
give mulighed for at evaluere hvilke parametre, der kræver opmærksomhed i 





I would like to acknowledge and express my gratitude to all the patients that 
participated in the studies. Without their willingness to participate, despite often 
having had numerous visits to their general practitioner, surgeons, and hospitals in 
general without experiencing much improvement, study II and IV could not have 
been initiated or completed. Similarly, study IV could not have been initiated if not 
for the financial support from the Department of Health Science and Technology at 
Aalborg University, the Danish Rheumatism Association, the Svend Andersen 
Foundation, and the Lions Denmark.  
This PhD thesis would not have been developed and completed without the assistance 
of my supervisors and collaborators. Especially, I would like to thank Professor 
Pascal Madeleine and Professor Lars Arendt-Nielsen for our collaboration. I am truly 
grateful that both of you were willing to allow me to combine your specific research 
areas with my own clinical experiences and ideas. Your supervision and our 
discussions have formed the foundation from which I am now finding my own path 
within the research. 
My collaborators for study IV deserve credit for assisting in bringing the project to 
fruition: Professor Søren T Skou for always being available to discuss any issue that 
may emerge and his ability to propose solutions, orthopedic surgeons Ole Simonsen 
and Mogens Laursen for sharing their clinical experiences and linking the study to 
the Department of Orthopedic Surgery. Furthermore, I wish to thank senior 
physiotherapists Jan Kjærsgaard, Michael Flyvholm Kvols, and Christine Nørgaard 
and the Departments of Occupational Therapy and Physiotherapy at Aalborg, 
Thisted, and Farsoe hospitals for their never-ending engagement and willingness to 
assist with various practical issues. I have been privileged to have skillful and 
engaged collaborators throughout my PhD. For study II, I thank Aina Lihn, Susanne 
Hybholt, and the rest of the personnel at SYNEXUS Aalborg (formerly Center for 
Clinical and Basic Research Aalborg) for their assistance in recruiting patients. For 
study III, I thank Lisbeth Mogensen, Karen Schur, and the rest of the personnel at 
Montebello – Department of Rehabilitation for being willing to collaborate and share 
their clinical results.  
I love going to work and immersing myself in the projects that I have commenced, 
but I love it, even more, when I return home to my wife Camilla, my son Anton, and 
my daughter Svea. Thank you for allowing me to spend so much time on research 
and for your presence that always reminds me of what the most important part of my 
life is. 
/ Jesper Bie Larsen, January 2021, Aalborg 
XI 
ABBREVIATIONS 
ADL Activities of daily living 
BMI Body mass index 
CI Confidence interval 
CPM Conditioned pain modulation 
ICC Intra-class correlation 
KOOS The Knee injury and Osteoarthritis Outcome Score 
MCID Minimal clinically important difference 
NEMEX-TJR The NEuroMuscular EXercise Total Joint 
Replacement training program 
NRS Numerical rating scale 
OA Osteoarthritis 
OARSI Osteoarthritis Research Society International 
PNE Pain neuroscience education 
PPT Pressure pain threshold 
QOL Quality of life 
QST Quantitative sensory testing 
SD Standard deviation 
SE Standard error 
SEM Standard error of the measurements 
TKA Total knee arthroplasty 
VAS Visual analogue scale 
XII 
PREFACE 
The scientific work related to this PhD thesis is the culmination of my time as a 
PhD student at Aalborg University, Aalborg Denmark. During my research, I spent 
time at and have been collaborating with other institutions for my data collection 
and interventions. Data collection for study I was conducted at Sport Sciences – 
Performance and Technology and Translational Pain Biomarkers at Aalborg 
University. Data collection for study II was made at the Department of 
Occupational Therapy and Physiotherapy at Aalborg University Hospital, Aalborg, 
Denmark, and at the outpatient clinic Center for Clinical and Basic Research, 
Aalborg, Denmark. Data collection for study III was conducted at Montebello – 
Department of Rehabilitation, North Zealand’s Hospital, located at Benalmádena 
Pueblo, Spain. Interventions and data collection for study IV is ongoing at three 
different locations within the Department of Occupational Therapy and 
Physiotherapy at Aalborg University Hospital, located in Aalborg, Farsoe, and 
Thisted, Denmark. 
The Svend Andersen Foundation, Lions Denmark, and the Danish Rheumatism 
Association funded study IV. The study sponsors were not involved in executing 
the study, interpreting the data, or publishing the results, and all the authors are 
independent of the sponsors. 
XIII 
LIST OF PAPERS 
The PhD thesis is based on four (I-IV) published manuscripts. In the thesis, the 
studies will be referred to according to their Roman numeral. 
I. Larsen JB, Madeleine P, Arendt-Nielsen L. Development of a new bed-
side-test assessing conditioned pain modulation: a test-retest reliability
study. Scand J Pain. 2019 Jul 26;19(3):565-574.
https://doi.org/10.1515/sjpain-2018-0353
II. Bie Larsen J, Arendt-Nielsen L, Simonsen O, Madeleine P. Pain,
sensitization, and physical performances in patients with chronic painful
knee osteoarthritis or chronic pain following total knee arthroplasty: An
explorative study. Eur J Pain. 2021 Jan;25(1):213-224.
https://doi.org/10.1002/ejp.1663
III. Larsen JB, Mogensen L, Arendt-Nielsen L, Madeleine P. Intensive,
personalized multimodal rehabilitation in patients with primary or revision
total knee arthroplasty: a retrospective cohort study. BMC Sports Sci Med
Rehabil. 2020 Jan 10;12:5.
https://doi.org/10.1186/s13102-020-0157-1
IV. Larsen JB, Skou ST, Arendt-Nielsen L, Simonsen O, Madeleine P.
Neuromuscular exercise and pain neuroscience education compared with
pain neuroscience education alone in patients with chronic pain after
primary total knee arthroplasty: study protocol for the NEPNEP




THESIS AT A GLANCE 
Figure 1 illustrates the coherence between the individual studies, leading towards the 
intervention study (study IV).  
Figure 1: Timeline from the potential development of knee osteoarthritis to total knee 




The PhD thesis aimed to develop a clinically applicable, bed-side test as a useful tool 
to examine conditioned pain modulation (CPM) (study I), to profile and compare pain, 
pain sensitization, patient-reported outcomes, and physical performances in patients 
with chronic pain after knee osteoarthritis (OA) or total knee arthroplasty (TKA) 
(study II). Furthermore, it aimed to investigate the benefits of an intensive, multimodal 
rehabilitation following primary or revision TKA (study III). Finally, it proposed to 
implement the findings from study I-III into an ongoing intervention study, which 
aimed at improving pain, pain sensitization, patient-reported outcomes, and physical 
performances in patients with chronic pain after TKA (study IV). Study IV is 
published as a study protocol. 
Study I: 
The main findings were as follows: 
 A new, spring-based pressure algometer was developed, which can be used
for applying test stimulus during CPM testing.
 The designed pressure algometer showed “good” relative reliability for test-
retest test stimuli, but the absolute reliability indicated substantial intra-
individual variation.
 No averaged CPM effect could be observed in a population of healthy
subjects.
 When CPM data were ranked individually, a distribution with both CPM
responders and non-responders was observed for all CPM test protocols
(Figure 2).
Figure 2: Individual CPM effects for all test protocols used in study I. Refer to study 
I for explanations of the different test protocols. Horizontal numbers refer to the 











































































































































































Test protocol 4 Positive values indicate facilitatory 
conditioned pain modulation (i.e. a 
non-responder). 
Negative values indicate inhibitory 
conditioned pain modulation (i.e. a 
responder).  
NRS: Numerical rating scale 




The main findings were as follows: 
 Similar profiles for pain intensity, pain sensitization, and patient-reported 
outcome measures were observed for the OA and the TKA groups with 
chronic pain. 
 Differences in physical performances were observed between groups, with 
the OA group consistently performing better physically. 
 No averaged CPM effect could be observed in the population of patients 
with chronic pain because of knee OA or after TKA. 
 When CPM data were ranked individually, a similar distribution as in study 
I with both CPM responders and non-responders was observed for both the 
OA and the TKA groups (Figure 3).  
Figure 3: Individual conditioned pain modulation (CPM) effects for knee 
osteoarthritis and total knee arthroplasty patients with chronic pain. VAS: Visual 
analog scale. Positive values indicate facilitatory CPM (i.e. a non-responder). 
Negative values indicate inhibitory CPM (i.e. a responder). Horizontal numbers refer 









The main findings were as follows: 
 Patients with primary (n= 166) and revision TKA (n= 51) that received 
intensive, multimodal rehabilitation showed improvements in pain 
intensity, patient-reported outcomes, and physical performances. An 
overview of the results is shown in Figure 4. 
Figure 4: Overview of outcomes for both the primary and the revision TKA groups 
 
Knee injury and Osteoarthritis Outcome Score (KOOS)4 is the mean of the four KOOS 
subscales: pain, symptoms, activities of daily living, and knee-related quality of life. Pre-rehab: 
Scores before rehabilitation. Post-rehab: Scores after rehabilitation. Error bars indicate standard 
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CHAPTER 1. INTRODUCTION  
1.1. OSTEOARTHRITIS AND TOTAL KNEE ARTHROPLASTY: 
MAGNITUDE AND BURDEN OF DISEASE  
Osteoarthritis (OA) is a frequent condition in the elderly population and it is estimated 
that more than 300 million people worldwide suffer from OA (1,2). In the overall 
Danish population, 21% suffers from OA and for the age group of 65+ years, the 
prevalence of OA ranges from 40-50% (3). This makes OA the second-most prevalent 
disease in Denmark, and it accounts for more cases than hypertension, 
migraine/recurrent headache, and diabetes (3). More specifically, hip and knee OA 
have the most significant effect on the overall OA burden and a global knee OA 
prevalence of 3.8% has been estimated (4). Expressed as a global disability, hip and 
knee OA ranked 11th among 291 conditions when years lived with a disability was 
evaluated in 2016, which was a rise from rank 17th in 1990 (4). For the Nordic 
countries (Denmark, Sweden, Norway, Iceland, Greenland, and Finland), hip and 
knee OA ranks 15th among the 30 leading causes of years lived with disability in 2015. 
Moreover, from 1990-2015, it had the fifth-highest relative increase in years lived 
with a disability (5). 
End-stage knee OA is often treated surgically with a total knee arthroplasty (TKA) 
(1,4) and it has been estimated that patients diagnosed with knee OA have a 30-50% 
lifetime risk of undergoing TKA (6,7). Due to aging, increased obesity rates, and a 
more sedentary lifestyle, the number of people with hip and knee OA is expected to 
increase in the future (1,4,8). Therefore, the number of TKAs performed has been 
growing and is expected to continue to rise (9,10). It has been estimated that if the 
increasing rate of TKA surgeries from 2003 to 2013 in Australia continues, 276% 
more TKA surgeries will be performed in 2030 compared to those in 2013 (11). In 
Denmark, 9.700 patients underwent a TKA in 2018, which is a rise of 14% compared 
to previous years (2011-2017), during which the surgery rate for TKA remained 
unchanged (12). In Denmark, a total of 1.100 patients had a revision TKA in 2018. 
The most common reasons for revision surgery was the aseptic loosening of an 
implant (19%), infection (18%), instability (18%), and pain without loosening of the 
implant (11%) (12). 
At an individual level, the burden of OA affects pain levels, physical performance, 
and quality of life (QOL) (13). Moreover, increased mortality in OA populations 
compared to general populations has been observed, especially regarding the risk of 
death from cardiovascular disease (14-18). Socioeconomically, people with OA have 
an increased risk of sick leave, a reduced employment rate, and early retirement, and 
the productivity costs of work loss are expected to increase by 46% from 2010 to 2031 
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in Canada (19). Recently, the total medical and non-medical expenses caused by OA 
are estimated to be an annual cost of $ 460 billion in the USA (20). 
1.2. OSTEOARTHRITIS AND TOTAL KNEE ARTHROPLASTY: 
PATHOLOGY AND SYMPTOMS  
1.2.1. PATHOLOGY 
Osteoarthritis is a disease that occurs in the synovial joints. It is most commonly 
observed in the hips, knee, hand, and spine joints and often affects several joints 
(5,21,22). Contrary to earlier assumptions, OA is now considered a whole disease and 
not only a disease related to the articular cartilage (23). The onset of OA can be caused 
by cell stress and extracellular matrix decomposition in the joint (21,24). The quality 
of the extracellular matrix is crucial for preserving the functional properties of the 
cartilage (21). The OA can be initiated from an abnormality in any of the synovial 
joint tissues, including articular cartilage (25), subchondral bone (26), ligaments (25), 
menisci (27), periarticular muscles (28), peripheral nerves (25), and/or synovium (29). 
These abnormalities can be caused by biomechanical (26,30), biochemical (31), 
and/or genetic factors (32). Osteoarthritis is characterized by degenerative changes in 
the articular cartilage and subchondral bone as the result of lack of joint regeneration 
(21,25,30). These changes lead to synovitis and thickening of the joint capsule 
(21,33). The loss of cartilage and the subsequent osteophyte formation causes joint 
space narrowing and structural changes in the bone (21,26,31). The structural changes 
of the bone and joint can gradually develop into malalignment of the joint (26). This 
stage of OA progression represents a vicious circle, leading to increased load-bearing 
of the affected focal areas of cartilage and bone. Thus, further cartilage damage and 
remodeling of the underlying bone occur, which creates further malalignment and 
degradation (26,30). 
1.2.2. SYMPTOMS 
Pain is the dominant symptom of OA (22,34-36). Other symptoms include joint 
stiffness (21,22,25,34,37), crepitus (21,22,37), swelling (21,22,37), reduced joint 
movement (21,22,37), and joint instability (22,37). These symptoms can 
progressively impose impaired sleep (25), mood changes (25), decreased QOL (25), 
and pain-related psychological distress (22,37). Furthermore, physical performance 
limitations (22,25,34,37), such as the impaired ability to walk and climb stairs, can 
limit the participation of previously appreciated activities, which leads to further 
reduced QOL (25).  
In the initial phase of OA, pain is often intermittent and mainly occurs during weight-
bearing activities. When the pain becomes more frequent and unpredictable, patients 
tend to characterize their pain as intolerable (22). This progression and chronification 
of pain, along with unacceptable activity limitations and severe end-stage OA, often 
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leads to these patients being offered a total knee arthroplasty (TKA) (10,22). The TKA 
procedure is regarded as a successful treatment for OA and has shown excellent results 
from a prosthesis perspective (38,39). However, it is estimated that about 20% of 
patients undergoing knee joint replacement will experience chronic pain following 
their surgery (10,22,40,41). The chronic postoperative pain is often followed by 
functional limitations with reduced walking distance and difficulties with climbing 
stairs and rising from a chair (39). Low QOL (40,42), and poor patient-reported 
outcomes (42) are exhibited when experiencing chronic pain after TKA. 
Psychological symptoms in terms of depression (38,43), anxiety (43,44), pain 
catastrophizing (45-47), fear-avoidance behavior (48) and poor pain self-efficacy(49) 
have all been associated with chronic pain following TKA. However, conflicting 
evidence for these psychological traits is present (50), making the impact of these 
parameters uncertain (49). 
Following the TKA surgery, problems can arise that can lead to a revision TKA. The 
most common causes of revision TKAs are infection, aseptic loosening of the implant, 
and periprosthetic fracture (10,51). Revision TKAs have also been used as a treatment 
for unexplained (e.g. not due to implant or infection factors) chronic pain after TKA 
(52), but the benefits of this have been questioned because of the low rates of treatment 
success (53). The positive effects, often seen after a primary TKA, are not as evident 
after revision TKA (52,54) and, therefore, revision TKAs do not appear to be an 
effective treatment of unexplained chronic pain after TKA (40,52,53). 
1.3. OSTEOARTHRITIS AND TOTAL KNEE ARTHROPLASTY: 
CHRONIC PAIN AND PAIN SENSITIZATION 
1.3.1. CHRONIC PAIN 
In their taxonomy, the International Association for the Study of Pain stipulates that 
when the pain has been present for at least three months, it is defined as chronic pain 
(55). The exact factors that influence the transition from acute to chronic pain are not 
completely understood (34). Initially, the OA pain is intermittent and is often related 
to loading and weight-bearing activities, which is believed to be a typical trait for 
nociceptive OA pain (56). The nociceptive pain input can originate from structural 
changes in the OA joint and synovitis (57). This can lead to peripheral sensitization 
(57), which is commonly observed as a reduction in pressure pain thresholds (PPT) 
(56,58). Over time, the continued nociceptive input can result in pain sensitization 
(see section 1.3.2), which can become a contributor to the chronic pain 
pathophysiology (22,56,57). 
The mechanisms and pathophysiology of OA pain are complex (57) and not fully 
understood (56). The progression towards chronic pain is thought to involve a 
combination of local pathological processes in and around the joint, genetic and 
metabolic factors, and neuronal changes at several levels, including peripheral and/or 
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central sensitization, reduced descending inhibition, and atrophy of cortical areas (56). 
The causes of chronic pain after TKA are largely unexplained (59). Similar to the 
chronic pain mechanisms in OA, peripheral and central sensitization has been 
observed in chronic pain patients following TKA (59,60). Patients have been shown 
to have complex causes of pain and, overall, it has been suggested that the chronic 
pain in patients after TKA is predominantly centrally driven (59,60). Similarly, in 
patients with chronic pain after revision TKA, signs of widespread pain, hyperalgesia, 
and enhanced temporal summation have been observed, indicating pain sensitization 
(61). 
Chronic pain should be considered in a biopsychosocial framework, which highlights 
the multifactorial reasons for chronic pain (35,36,62,63). Thus, the severity of chronic 
pain can be influenced by factors such as sleep (22,25), mood/depression (22,43), 
systemic inflammation (64), and pain catastrophizing (45-47). Therefore, a 
biopsychosocial approach is important when managing patients with chronic pain 
(62,65).  
1.3.2. PAIN SENSITIZATION  
Pain sensitization has been proposed as an important factor in developing chronic pain 
(66,67). The International Association for the Study of Pain defines sensitization as 
“Increased responsiveness of nociceptive neurons to their normal input, and/or 
recruitment of a response to normally subthreshold inputs” and distinguishes between 
central and peripheral sensitization (68). Central sensitization refers to “increased 
responsiveness of nociceptive neurons in the central nervous system” whereas 
peripheral sensitization refers to “increased responsiveness and reduced threshold of 
nociceptive neurons in the periphery” (68). Sensitization was initially described in 
animal models (69). In animals, it is possible to assess the development of 
sensitization using invasive measurements in the spinal cord and brain (70,71). In 
humans, it is possible to measure sensitization as a proxy, parallel to the output in 
animals (70). Animal studies have observed findings of hyperalgesia and allodynia 
(i.e. pain experienced due to a stimulus that would not normally induce pain) in pain-
sensitization models, which infer that these mechanisms, when observed in humans, 
could be interpreted as signs of pain sensitization (71). 
The mechanisms behind pain sensitization are not completely elucidated (56) and are 
thought to include both central and peripheral aspects, which can lead to the 
development and maintenance of chronic pain (72). This pain hypersensitivity is 
thought to be caused by initial nociceptive inputs, leading to amplification of neural 
signals and hyperexcitability of nociceptors (56,66,67,72). These structural changes 
can occur due to the plasticity of the nervous system (66,67,72). An important element 
of central sensitization is the “wind-up,” which refers to repetitive stimuli that lead to 
temporal summation of pain and, thereby, a pain response (72). If central sensitization 
is present, this hyperexcitable state will lead to enhanced temporal summation, which 
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will generate a higher pain response than in healthy controls (72,73). Pain 
sensitization can manifest itself as allodynia (67,74) (pain response from a non-
noxious stimulus), hyperalgesia (67,73,74) (increased pain response from a noxious 
stimulus), and widespread pain symptoms (67,74,75). Several studies have observed 
pain sensitization in OA patients (58,76), TKA patients (59,60), and in patients after 
revision TKA (61), thereby highlighting the importance of pain sensitization for the 
development and maintenance of chronic pain in chronic pain conditions (56,72).  
Descending inhibition is another mechanism of interest in pain sensitization, and this 
mechanism has been described as a further important factor behind the development 
of chronic pain (77,78). In animal studies, the inhibitory control of nociceptive 
excitability, through lower brainstem mediated inhibitory mechanisms, can be 
observed (70,79). Originally, this was termed diffuse noxious inhibitory control in 
animals (80). In humans, this descending inhibition mechanism is referred to as 
conditioned pain modulation (CPM) (80) and describes the mechanisms by which the 
brain can modulate pain-facilitating signals using pain inhibitory signals (70,81). In 
humans, it is not possible to differentiate between inhibition and facilitation, and only 
the net sum can be assessed (70,80). Therefore, CPM is thought to reflect the balance 
between descending pain inhibitory and facilitatory mechanisms (56,80,82,83). In 
most healthy subjects, a CPM effect can be observed (78), although variations occur 
(81,84), whereas in patients with chronic pain conditions, often no CPM effect is 
observed (79,81,85,86). However, it is not uncommon to observe variation in the 
distribution of CPM responders and non-responders (83,86-89). This variation of 
CPM effect in patients with chronic pain is not fully understood (90). 
Pain sensitization can be measured using different methods and no gold standard for 
evaluating pain sensitization exists (76,91,92). Quantitative sensory testing (QST) has 
been used for mechanistic profiling of pain mechanisms and pain sensitization 
(76,93,94). These methods include the measurement of mechanical and thermal 
detection thresholds, wind-up, mechanical and thermal pain threshold and sensitivity, 
a thorough protocol for QST has been developed (95,96). However, QST tests are 
time-consuming, require the introduction and teaching of the methods and costly 
equipment, which hinders the implementation of these methods in routine clinical 
settings (97-99). This highlights the need for the development of clinically applicable 
bed-side tools. Currently, it is suggested that the measurement of pain sensitization 
could include evaluation of temporal summation of pain, pain thresholds using PPT 
algometers, and pain hypersensitivity using pinpricks or a brush, which should be 
evaluated in localized and extra-segmental areas (73,97). Conditioned pain 
modulation evaluation has been proposed, which would use the cold presser test as 
conditioning stimulus and PPTs as test stimulus (83,100), and cuff-induced pressure 
pain as both conditioning and test stimuli (101,102). Challenges of implementing 
these methods into routine clinical settings are present due to the requirement of 
laboratory equipment, such as an ice-water bath or computer-controlled cuff pressure 
algometry. This warrants the development of clinically applicable CPM tools (103).  
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1.4. OSTEOARTHRITIS AND TOTAL KNEE ARTHROPLASTY: 
TREATMENT OF CHRONIC PAIN, PAIN SENSITIZATION, 
AND PHYSICAL PERFORMANCES  
1.4.1. CLINICAL PRACTICE GUIDELINES 
Numerous clinical guidelines and systematic reviews have highlighted exercise and 
education as first-line treatments for hip and knee OA (104-109). The introduction of 
OA management programs, such as GLA:D (110), backed by evidence-based 
knowledge (111), has led to joint replacement surgery being recommended as the last 
treatment option (109) (Figure 5). 
 
Fig. 5. The osteoarthritis treatment pyramid. Osteoarthritis of the hip and knee is best managed 
using education, exercise, and weight control with the addition of pharmacological and surgical 
interventions when needed. All patients should be offered first-line treatment, while some will 
need second-line treatment, and few will need third-line treatment. *Passive treatments include 
manual therapy, acupuncture, and other treatments given by a therapist and not requiring an 
active lifestyle change by the patient. Figure and text are reprinted with permission (109). 
While pharmacological treatment has been conditionally recommended as a treatment 
for OA (104), evidence suggests that exercise is prescribed less frequently than 
pharmacological or surgical treatments (112). Analysis from the United States has 
shown that opioid and non-opioid medications were prescribed more frequently than 
physiotherapy and counseling for the management of chronic musculoskeletal pain, 
including OA (113). No clinical or standardized regimens are available to patients 
with chronic pain after TKA (114,115). Since no clear treatment recommendations 
are available, treatment is more likely to be based on the health-care practitioner’s 
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experiences and preferences rather than on evidence-based knowledge. High-quality 
studies examining possible treatment options are, therefore, warranted (114,115). 
1.4.2. EXERCISE AS TREATMENT 
Exercise is defined as “a subcategory of physical activity that is planned, structured, 
repetitive, and purposeful in the sense that the improvement or maintenance of one or 
more components of physical fitness is the objective” (116). Given this broad 
definition, a variety of different types of exercise as treatment exists. Overall, exercise 
can be categorized as aerobic or strengthening and can be performed as land-based or 
aquatic exercise, or it may focus on neuromuscular coordination (117). The use of 
exercise as a treatment for OA has recently been shown to elicit moderate-to-high 
effects on pain and physical performances (118,119), with no single type of exercise 
superior to another (106,117,120).  
The mechanisms behind the effect of exercise on chronic pain are not fully understood 
(65,121,122). It has been suggested that central, peripheral, systemic, and 
psychological effects occur because of exercising (117,123,124). Reduced pain 
sensitivity following exercise is often referred to as exercise-induced hypoalgesia 
(125-127). Exercise is thought to induce activation of the endogenous opioid and 
serotonin systems and through enhanced activation of the CPM system, which results 
in endogenous analgesia (123,125,128). The systemic effects have been proposed to 
occur due to an increase in anti-inflammatory cytokines, possibly resulting in reduced 
systemic inflammation (124,129,130). However, the influence of exercise on systemic 
inflammation is not fully known (117). The psychological effects of exercising may 
relate to less pain catastrophizing, less fear of movement, and improved self-efficacy, 
which are elements involved in the presence of chronic pain (123,131). Furthermore, 
the sensorimotor function can be mediated by pain (35,117). This can result in 
alterations in motor unit recruitments and incomplete activation of the muscles, which 
can lead to poor coordinated timing of muscle contractions, joint instability, and lack 
of postural control (132-134). Exercise has been shown to induce functional gains in 
muscle strength, proprioception, and mobility in patients with chronic pain following 
exercise (117,121,135). Such peripheral improvements are associated with pain relief 
in knee OA patients (121,127,135). Improvements in physical performances 
following exercise have been observed in patients with knee OA and after TKA, 
including improved walking distance and speed (111,136-139), improved ability to 
climb stairs (137,138,140), improved ability to perform functional tasks such as chair 
rises (137,140) and timed up and go (111,138), and increased muscle strength 
(139,141). 
Neuromuscular exercise has been widely used as a treatment for hip and knee OA and 
after TKA surgery (111,139,142,143). Neuromuscular exercise consists of functional, 
weight-bearing exercises, which focus on the quality of the movements as well as 
optimal activation and loading of the muscles, thereby enhancing sensorimotor 
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control, joint alignment, and postural control (134,143). Neuromuscular exercises 
have been demonstrated to be effective in treating pain and improving physical 
performances in patients with hip and knee OA (134,139,144) and as an early post-
operative treatment after joint replacement (111), but they have not been investigated 
as a treatment option for patients with chronic pain after TKA.  
1.4.3. PAIN EDUCATION AS TREATMENT 
Education as a treatment for patients with chronic pain has traditionally been based 
on a biomedical approach, but the increased knowledge of the multifactorial reasons 
behind chronic pain has led to a shift in the education focus towards a biopsychosocial 
approach (145,146). The predominantly patient-centered focus, rather than an 
anatomical focus, is believed to be important for the management of chronic pain 
(63,147). This has led to the development of pain neuroscience education (PNE), 
which focuses on explaining the multifactorial nature of chronic pain, the 
characteristics of acute and chronic pain, how pain can become chronic (plasticity of 
the nervous system), and the multifactorial factors that can influence the presence and 
experience of chronic pain (146,148). Pain neuroscience education has been suggested 
as a useful type of education for patients with chronic pain (147,148). Pain 
neuroscience education aims to re-conceptualize the beliefs about pain and decrease 
the potential threat experienced from the pain, which involves less pain 
catastrophizing and less kinesiophobia (146,147,149). Studies that implement PNE as 
part of the pain management have shown mixed results with either similar effects on 
pain outcomes as usual care (i.e. traditional education) (146,150), clinically non-
significant changes (147), improved pain outcomes (151,152), or improvement in 
psychological parameters, such as pain catastrophizing and kinesiophobia 
(146,147,151-153). Pain neuroscience education has been proposed to be most 
efficient when delivered in conjunction with exercise (149,152). Pain neuroscience 
education has mainly been investigated for its role in treating chronic musculoskeletal 
disorders (147,151,152) or as a preoperative treatment to prevent post-operative pain 
(146,150). It has never been used as a later phase post-operative treatment for patients 
with chronic pain after TKA. 
1.4.4. TREATMENT OF PAIN SENSITIZATION 
Pain sensitization appears to play an important role in the development and 
maintenance of chronic pain (56), and it attracted interest in the exploration of how 
pain sensitization evolves and the establishment of effective treatment options. Non-
conservative interventions, for example, knee-replacement surgery, have been 
examined for their effect on pain sensitization. Since pain sensitization is believed to 
be initiated by peripheral nociceptive input (56,66,67,72), surgical treatment has 
attempted to eliminate the source of the nociceptive input based on the assumption 
that this might reverse or “remove” the pain sensitization (154). Results are conflicting 
and some studies have reported a decrease in pain sensitization following TKA (155-
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157), whereas others report no effect on pain sensitization following TKA (158,159) 
or even widespread sensitization in patients with pain following revision TKA (61). 
Several studies have examined the effect of pain sensitization on treatment outcomes 
and found pain sensitization to predict a worse outcome after TKA (100,160,161), 
although a systematic review concluded that the findings of the predictive value 
regarding chronic postoperative pain are inconsistent (162).   
Conservative interventions have also been investigated as treatments of pain 
sensitization and have consisted of physical activity, exercise, education, as well as 
manual therapy and pharmacological treatment, which are beyond the scope of this 
thesis. As with the outcomes following surgical interventions, conflicting evidence 
exists. Most studies demonstrate that exercise decreases pain sensitization (157,163-
165), but have also been shown not to modulate pain sensitization (159). In a 
systematic review and meta-analysis, exercise decreased pain sensitization 
immediately following exercise, but not after a period of exercising (166). The authors 
concluded that limited evidence formed the base for their findings (166). Pain 
sensitization in knee OA patients has been shown to predict non-response from 
physiotherapy treatment that consisted of exercise programs (167). Pain neuroscience 
education has been proposed as a treatment option for pain sensitization (148,168), 
possibly by reducing pain catastrophizing and kinesiophobia (146,147,149). As with 
the other listed interventions, results are conflicting with evidence pointing both 
towards decreased pain sensitization following PNE in some studies (149,169) and no 
changes in pain sensitization in other studies (164,170). Overall, pain sensitization 
appears to be somewhat treatment-resistant, and more research regarding this topic is 
required to establish an effective treatment (148,171). Because of the complex and 
multifactorial mechanisms behind chronic pain and pain sensitization, it has been 
argued that studies combining multimodal interventions, for example, exercise and 
education, are warranted (172). 
1.5. SUMMARY OF BACKGROUND 
Figure 6 provides a summary of the background. 
Figure 6: Fact box 
Multifactorial mechanisms underlie chronic pain due to knee OA or after TKA and 
include several factors, such as local pathological processes in the joint, genetic 
and metabolic factors, and pain sensitization. 
Pain sensitization appears to be an important feature of chronic pain mechanisms, 
highlighting the need for clinically applicable bed-side tools to measure pain 
sensitization in routine clinical settings.  
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Clinical guidelines have firmly established recommendations of conservative 
treatments, such as exercise and education for knee OA patients. No evidence-
based clinical guidelines or treatment recommendations are available for patients 
with chronic pain after TKA. 
Neuromuscular exercise is effective for decreasing pain and improving physical 
performances in knee OA patients, and pain neuroscience education has been 
proposed as a useful treatment for chronic pain. This suggests that a combination 
of neuromuscular exercises and pain neuroscience education could potentially be 
an effective treatment for patients with chronic pain after TKA. 
 
1.6. AIMS AND HYPOTHESIS OF THE PHD PROJECT 
The PhD thesis aims to 
1) Examine pain, pain sensitization, CPM, patient-reported outcomes, and physical 
performances in patients with chronic pain after knee OA or TKA by using 
quantitative pain assessment and evaluating outcomes after conservative 
interventions. 
The specific aims and hypotheses of the individual studies: 
Study I: 
1) Develop a new and feasible screening test to evaluate CPM in clinical settings. 
It was hypothesized that a simple, handheld, spring-based pressure algometer as test 
stimulus and a standard clamp as a conditioning stimulus would be able to induce a 
CPM effect in healthy subjects and that the proposed method would be reliable. 
Study II: 
2) Profile and compare pain outcomes, pain sensitization, patient-reported outcomes, 
and physical performances in patients with chronic pain from knee OA or after TKA 
using clinically applicable bed-side methods to evaluate pain sensitization and CPM. 
Furthermore, to examine associations between physical performances, patient-
reported function, pain intensity, and quantitative sensory profiling outcomes. 
The hypothesis was that indications of pain sensitization (defined as temporal 
summation of pain) would be more prevalent in patients with chronic pain after TKA 
compared to OA patients. 
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Study III: 
3) Analyze the benefits of a three-week intensive, multimodal rehabilitation regimen 
on pain, patient-reported outcomes, and physical performances in patients with pain 
and impaired physical performances after primary or revision TKA. 
It was hypothesized that pain intensity, patient-reported outcomes, and physical 
performances would improve after the three-weeks of intensive, multimodal 
rehabilitation. 
Study IV: 
4) Investigate the effects of a 12-week neuromuscular exercise program combined 
with PNE on pain outcomes, pain sensitization, patient-reported outcomes, and 
physical performances in patients with chronic pain after TKA. 
The study hypotheses propose that treatment consisting of neuromuscular exercises in 
conjunction with PNE can decrease pain intensity and pain sensitization and improve 
patient-reported outcomes and physical performances after 12 months.  
 
13 
CHAPTER 2. METHODS 
2.1. STUDY DESIGN 
Study I was a test-retest reliability study and study II was a cross-sectional profiling 
study. Study III and IV were/are intervention studies. Study III was a retrospective 
cohort study and study IV is an ongoing randomized controlled superiority trial (RCT) 
with a 1:1 treatment allocation. The study IV manuscript is a protocol for the ongoing 
trial. 
2.2. POPULATIONS  
2.2.1. STUDY I 
Study I consisted of two cohorts of healthy subjects. The cohort for reliability 
evaluation consisted of 22 subjects and the cohort for the methodological evaluation 
consisted of 29 subjects. All subjects were recruited using postings on the Aalborg 
University campus site. According to the inclusion criteria, subjects had to be between 
18-40 years old, did not have any pain, and were not allowed to consume alcohol or 
pain medication on the days of the test. The reliability part was conducted according 
to the Guidelines for Reporting Reliability and Agreement Studies (173). The study 
was conducted according to the Helsinki declaration and the local ethics committee 
of the North Denmark Region approved the study (N-20170088). Oral and written 
information were provided to the subjects prior to inclusion and informed consent was 
obtained from all subjects (study I). 
2.2.2. STUDY II 
Study II included a population of 70 patients with chronic pain from knee OA (n= 46) 
and chronic pain after TKA (n= 24). Potential eligible patients were identified using 
patient medical journals from the Department of Orthopedic Surgery, Aalborg 
University Hospital, Denmark, and from the outpatient clinic Center for Clinical and 
Basic Research, Aalborg, Denmark. Patients were eligible to participate if they 
fulfilled the inclusion criteria of 1) knee OA diagnosis according to the American 
College of Rheumatology criteria (174) based on clinical and radiographic evidence 
of ≥ grade 2 or having a primary TKA, 2) duration of pain for at least six months, 3) 
average daily pain intensity for the last week of at least 4/10 on a numerical rating 
scale (NRS, with “0” representing “no pain” and “10” representing “worst pain 
imaginable”), 4) aged between 40-80 years, and 5) body mass index (BMI) between 
19-40 kg/m2. Exclusion criteria were 1) secondary causes of arthritis to the knee, 2) 
surgery (including arthroscopy) of the knee within the three months before inclusion, 
3) acute pain affecting lower limb or back at the time of participation, and 4) 
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rheumatoid arthritis, neurologic illnesses or primary pain area other than the knee. 
The study adhered to the guidelines from the Strengthening the Reporting of 
Observational Studies in Epidemiology Statement (175). The study was conducted 
according to the Helsinki Declaration and was approved by the local ethics committee 
of the North Denmark Region (N-20170088). Oral and written information were 
provided to the subjects prior to inclusion and informed consent was obtained from 
all subjects (study II). 
2.2.3. STUDY III 
Study III included a population of 217 patients with primary (n= 166) or revision TKA 
(n= 51). All patients were referred to a three-week rehabilitation stay at Montebello, 
Department of Rehabilitation, North Zealand’s Hospital, Denmark. To be referred to 
the rehabilitation department, patients must have had post-surgical complications, for 
example, persistent pain, continued functional impairment, lack of effect from initial 
post-surgical rehabilitation, infection, or implant failure. The patient’s surgeon or 
family physician evaluated whether post-surgical complications were present. 
Because retrospective, register-based data was used for the analysis, the local ethics 
committee of the North Denmark Region waived the need for ethical approval. The 
Danish Data Protection Agency approved the study (study III).  
2.2.4. STUDY IV 
The ongoing RCT aims to include 120 patients with chronic pain after primary TKA. 
Patients will be recruited from the Department of Orthopedic Surgery, Aalborg 
University Hospital, Denmark. Using a computer-generated random numbers system, 
the included patients are being randomized in a 1:1 ratio to receive either 1) a 
neuromuscular exercise program (NEMEX-TJR) and PNE or 2) PNE alone. Screening 
of eligibility is conducted for patients referred to the orthopedic department as well as 
those using the hospital’s research database to identify patients with TKA. Inclusion 
criteria are 1) age between 40-80 years, 2) BMI between 19-40 kg/m2, 3) primary 
TKA due to OA and for at least 12 months post-operatively, 4) duration of knee pain 
for at least 6 months, and 5) average daily pain intensity for the last week of at least 
4/10 on NRS. Major exclusion criteria were 1) chronic pain due to implant failure that 
requires revision surgery, 2) secondary reasons for arthritis in the knee, 3) primary 
pain area other than the knee (e.g. low back pain), or neurological illnesses. The study 
protocol conformed to the guidelines of the Standard Protocol Items: 
Recommendations for Interventional Trials (176), and study interventions were 
described according to the Template for Intervention Description and Replication 
checklist (177) and the Consensus on Exercises Reporting Template checklist (178). 
The study is being conducted according to the Helsinki declaration, and the local 
ethics committee of the North Denmark Region has approved the study (N-
20180046). Before patient inclusion, the trial was registered at ClinicalTrials.gov 
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(NCT03886259). Oral and written information are provided to the subjects prior to 
inclusion and informed consent is being obtained from all subjects (study IV). 
2.3. INTERVENTIONS   
2.3.1. STUDY III 
Patients referred to the rehabilitation department will undertake a standardized, 
multimodal rehabilitation regimen over three weeks. The rehabilitation regimen 
consisted of group-based exercise derived from evidence-based exercise programs 
(143,179). The general focus of the various exercise sessions was to promote 
neuromuscular function, the flexibility of muscles and joints, postural control, 
walking ability by re-training gait patterns, muscle strength, and cardiovascular 
capacity. Patients attended two to four exercise sessions per day, with each session 
lasting 30-50 min. For further information on the specific exercises and exercise 
frequency and magnitude, please refer to the additional files of the study III 
manuscript. Load, difficulty level, and magnitude of exercise sessions were 
personalized according to the individual level of the patients and were based on 
parameters such as physical ability, pain, and fatigue. Patients attended educational 
sessions that provided information on pain self-management, the prosthetic knee 
implant, the importance of exercising, and the planning of continued exercising and 
self-management following discharge. Physiotherapists supervised all rehabilitation 
activities, including the educational sessions (study III). 
2.3.2. STUDY IV 
Interventions are taking place at three local Departments of Occupational Therapy and 
Physiotherapy (Aalborg, Farsoe, and Thisted), which are all part of the Aalborg 
University Hospital. Patients allocated to the neuromuscular exercise and PNE group 
are undergoing a 12-week rehabilitation period with bi-weekly exercise sessions that 
consist of the NEMEX-TJR program (143). The NEMEX-TJR program (for details 
see Ageberg et al. 2010) consists of a warm-up session of ergometer cycling, which 
is followed by a circuit program. The circuit program focuses on postural control, joint 
positioning and alignment, muscle strength, and functional exercises to improve the 
activities of daily living. The neuromuscular exercises are conducted in two to three 
sets with 10 to 15 repetitions in each set. Physiotherapists that are specially trained in 
the NEMEX-TJR program supervise all exercise sessions, thereby allowing 
individualization, for example, progression or regression of exercise difficulty. If the 
patients experience a major flare-up of pain related to exercise, the intensity and 
volume of the exercise are reduced until symptoms “are as usual” (143). Since the 
patients experience chronic pain, a time-contingent approach is used instead of a 
pain/symptom-contingent approach (154)). 
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The content of the PNE sessions is the same for both groups. The PNE consists of two 
group-based sessions of one hour each. One session takes place before the first 
exercise session and the other session takes place after six weeks of exercising. The 
PNE-alone group also receives the two sessions separated by six weeks. A PNE-
trained physiotherapist conducts the sessions, which focus on topics such as the 
multifaceted causes of chronic pain and pain sensitization, including terms such as 
hyperalgesia, allodynia, and self-management. The group-based sessions allow for 
questions and experience sharing between the patients. Following the sessions, a short 
information leaflet, summing up the content of the educational sessions, is provided 
to the patients (study IV). 
2.4. ASSESSMENT AND OUTCOMES  
An overview of all outcome measures included in the thesis can be seen in table 2. 
2.4.1. STUDY I  
The assessment of CPM was performed at the laboratories of the Department of 
Health Science and Technology at Aalborg University. The experimental procedure 
for the reliability part lasted approx. 10 minutes and the procedure was repeated after 
24-48 hours after the first session. For the methodological part, one session was 
performed, which lasted approx. 30 minutes.  
For both study cohorts, demographic information regarding age, sex, and dominant 
leg were retrieved before testing. In the test-retest part, the CPM effect was measured 
using a spring-based 6 kg pressure algometer (SMI, Aalborg University) as the test 
stimulus and a standard clamp, which induced a pressure of 1.3 kg, as conditioning 
stimulus. While the subjects were lying in a relaxed, supine position, the test stimulus 
was applied to the tibialis anterior muscle belly at the dominant leg and the 
conditioning stimulus was applied to the ipsilateral ear lobe. For the test-retest part, 
the test stimulus was applied for 10 sec, followed by a pain intensity rating of the test 
stimulus using a 0-10 NRS (with “0” representing “no pain” and “10” representing 
“worst pain imaginable”) (180,181). Following the pain rating, the clamp was 
attached to the earlobe for 60 sec, followed by a pain intensity rating of the 
conditioning stimulus using an NRS. This was followed by the immediate application 
of the test stimulus for 10 sec, while the conditioning stimulus was still applied to the 
ear lobe. Lastly, the subjects rated the pain intensity of the test stimulus on an NRS, 
this time while the conditioning stimulus was present. To conduct the test-retest part, 
the second CPM test session was repeated 24-48 hours following the first test session 
(study I). 
For the methodological part, the three test protocols were conducted in a randomized 
order, and tests were separated by a 10 min. break to avoid any carry-over effects. 
Test areas, subject position, and test procedures were identical with the areas 
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described in the test-retest part. The pressure algometer induced a force of 6 or 10 kg 
and the standard clamps induced a force of 1.3 kg each. An overview of the different 
CPM test protocols can be seen in Table 1. Pain intensity ratings for the 
methodological part were measured using a visual analogue scale (VAS, with one end 
representing “no pain” and the other end representing “worst pain imaginably) 
(180,181). The author of the thesis performed all CPM tests in both study cohorts 
(study I). 
Table 1: Overview of experimental test protocols for the test-retest part and the 
methodological part. 
Test protocol Test stimulus Conditioning stimulus 
1 
(Test-retest part) 
6 kg spring-based 
pressure algometer 
applied for 10 sec 
One standard clamp (1.3 kg) 




10 kg spring-based 
pressure algometer 
applied for 10 sec 
Two standard clamps (1.3 kg 




10 kg spring-based 
pressure algometer 
applied for 10 sec 
One standard clamp (1.3 kg) 




6 kg spring-based 
pressure algometer 
applied for 10 sec 
One standard clamp (1.3 kg) 
applied for 120 sec 
 
2.4.2. STUDY II 
The outcome assessment took place at the Department of Occupational Therapy and 
Physiotherapy at Aalborg University Hospital, Aalborg, Denmark, or at the outpatient 
clinic Center for Clinical and Basic Research, Aalborg, Denmark. The examination 
took place during a single session, which took approximately two hours. Patient 
characteristics were retrieved before assessing the outcomes and included age, sex, 
BMI, the time since knee OA diagnosis, and the time since surgery. The testing 
sequence was predetermined and started with pain and pain-sensitization-related 
outcomes, completion of patient-reported outcome measures, and finally, the physical 
performance tests. During the pain and pain sensitization examination, patients lay in 
a comfortable, supine position. The author of the thesis conducted all outcome 
assessments in the study (study II). 
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Pain intensity 
Assessment of pain intensity was conducted by asking the patients to rate “the average 
pain intensity in the knee over the last week” on an NRS in which the perceived pain 
intensity was chosen from a range between 0-10 with “0” representing “no pain” and 
“10” representing “worst pain imaginable” (study II).  
Pain sensitization 
The quantitative sensory profiling of pain sensitization was conducted using clinical 
applicable bed-side tests (Figure 7). The bed-side screening tool consisted of 
mechanical pinprick pain sensitivity, mechanical temporal summation, and CPM.  
Mechanical pinprick pain sensitivity was examined using a nylon filament of 0.7mm 
(Chicago Medical Supplies, Chicago, USA). The nylon filament was applied 
perpendicular to the skin (90° angle) until the filament was slightly bent, which occurs 
when a force of 75 grams is applied. The patients rated the pain intensity of the single 
pinprick on an NRS. This procedure was performed at two test areas, both localized 
at the most affected knee (index), 10 cm above the knee on the ventral thigh and extra-
segmentally at the muscle belly of flexor digitorum superficialis, located on the medial 
side of the forearm. 
Mechanical temporal summation was examined using the nylon filament described 
above. First, a single pinprick stimulus was applied perpendicular to the skin and the 
patients were asked to rate the pain intensity on an NRS. Thereafter, a series of 10 
repeated pinprick stimuli were applied within an area of 1 cm2 with a repetition rate 
of 1/second, which is similar to the single pinprick stimulus, and after the 10th pinprick 
stimulus, patients rated the pain intensity on an NRS. The test was performed at the 
same test areas as for the mechanical pinprick pain sensitivity test. 
Conditioned pain modulation was assessed using the bed-side CPM method 
developed in study I. As a test stimulus, the 6 kg pressure algometer was applied for 
10 sec on the mid part of the tibialis anterior muscle on the contralateral side of the 
index knee. Following this, test stimulus pain intensity was rated on a VAS slider. As 
a conditioning stimulus, a standard clamp inducing a force of 1.3 kg was attached to 
the ipsilateral ear lobe for 60 sec. After 60 sec, the conditioning stimulus pain intensity 
was rated using a VAS slider and followed by the re-application of the test stimulus 
for 10 sec, while the clamp was still attached to the ear lobe. Thereafter, the test 
stimulus pain intensity was rated using a VAS slider (study II). 
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Figure 7: Illustration of the bed-side tools used for the quantitative sensory profiling 




Patient-reported outcome measures 
As patient-reported outcomes, the Knee Injury and Osteoarthritis Outcome Score 
(KOOS) questionnaire was included. The KOOS consists of five domains that 
encompass pain, symptoms, ADL, sports and recreational activities, and knee-related 
QOL. Each domain includes several items, which are scored on a 5-point Likert scale, 
ranging from 0 (none) to 4 (extreme) and the overall outcome score ranges from 0 
(worst) to 100 (best) (182). The score of each domain was recorded as the outcome 
(study II). 
Physical performances 
Assessment of physical performance related to activities of daily living followed the 
recommendations from OsteoArthritis Research Society International (OARSI) (183) 
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and included the 30-second chair stand test, the 40-meter fast-paced walk test, and the 
stair climb test. The chair-stand test has the patient rising and sitting down as many 
times as possible in 30 seconds. Patients were instructed to place their arms across the 
chest and when rising and to fully extend their knee and hips. The numbers of 
repetitions were the outcome score (183,184). For the 40-meter fast-paced walk test, 
patients were instructed to walk as fast as possible along a 10-meter walkway, turn 
around a cone, walk back again, and repeat this for a total distance of 40 meters. 
Regular walking aids, such as a cane, were allowed if patients felt this was necessary. 
The time it took to complete the 40 meters of walking was registered as the outcome 
score (183,184). The stair-climb test consisted of nine stairs, which the patients were 
instructed to ascend and descend once as fast as possible. Patients were allowed to use 
the handrail to maintain balance if needed. The time it took to complete the test was 
registered as the outcome score (183,184) (study II). 
2.4.3. STUDY III 
The assessment of outcomes was part of the rehabilitation department’s test battery 
for evaluating the overall effects of the treatment during the hospital stay. Therefore, 
assessments were made after hospitalization and again before discharge. 
Demographic information regarding age, sex, BMI, and time-since-surgery were 
registered. As the primary outcome, the patient-reported outcome measure KOOS, 
which was introduced and used in study II, was completed. For this study, the KOOS 
domain sports and recreational activities were not included, since it represents 
strenuous activities, such as running, jumping, and kneeling, and surgeons often 
explain to their patients that such activities are contraindicated. Assessment of pain 
intensity was made by asking the patient to rate the pain intensity during activity (e.g. 
walking, biking, or stair climbing) using an NRS. The physical performances of the 
patients was evaluated using tests recommended by the OARSI (183,184). The 6 min. 
walking test assesses the walking ability and aerobic capacity. Patients were told to 
walk along a 21 m long walkway, circumvent a cone, walk back again, and then repeat 
this for 6 min. Patients were instructed to walk as fast as possible and the number of 
meters covered during the test was the outcome score (183,184). The stair-climb test 
(introduced in section 2.4.2) consisted of a staircase of 22 steps, which the patients 
were asked to ascend and descend once as quickly as possible. The time it took to 
complete the task was the outcome score. The physiotherapists working at the 
rehabilitation department in the study period performed the outcome assessments 
(183,184) (study III). 
2.4.4. STUDY IV 
The assessment of outcomes is taking place at the Department of Occupational 
Therapy and Physiotherapy at Aalborg University Hospital, Aalborg, Denmark. The 
assessment of outcomes is conducted at baseline before randomization and is repeated 
at 3, 6, and 12 months after initiation of the intervention. Assessment sessions take 
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approximately two hours. Blinded outcome assessors are assessing the participating 
patients. The experiences with the development and use of the CPM paradigm in study 
I and II, the experiences with bed-side sensitization outcome measures in study II, the 
experiences with patient-reported outcomes and physical performances in study II and 
III, and the observed benefits of exercise as a treatment in study III led to the outcomes 
included in study IV. A detailed description of the included outcome measures forms 
part of the study protocol. The primary outcome is the KOOS4, which is the mean 
score of the KOOS domains of pain, symptoms, ADL, and knee-related QOL (111). 
The secondary outcomes are categorized as patient-reported outcomes, pain and pain 
sensitization related outcomes, and physical performance outcomes (Table 2).  
Table 2: List of outcomes included in the thesis. Outcomes are categorized as pain 
and pain-sensitization related, patient-reported, or related to physical performances. 
For a specific description of the outcomes, refer to the individual studies. 
Outcome measures Study I Study II Study III Study IV 
Pain and pain sensitization  
Pain intensity  x x x 
Pain location    x 
Pressure pain thresholds    x 
Pinprick hyperalgesia  x  x 
Mechanical temporal 
summation 
 x  x 
Dynamic mechanic allodynia    x 
Deep somatic hyperalgesia    x 
Conditioned pain modulation x x  x 
Patient-reported outcomes  
Knee injury and 
Osteoarthritis Outcome 
Score 
 x x x 
PainDETECT    x 




   x 
Global perceived effect    x 
Pain catastrophizing scale    x 
Physical performances  
Chair stand test  x  x 
Walk test  x x x 
Stair climb test  x x x 
Maximal isometric 
quadriceps and hamstrings 
muscle strength 
   x 
Leg extension power    x 
 
Furthermore, adverse events because of the intervention, adherence to the 
intervention, and whether other treatments were received are continuously registered. 
Before baseline testing, demographic parameters, such as age, gender, BMI, time-
since-surgery, comorbidities, and scores on the Hospital Anxiety and Depression 
Scale are recorded (study IV). 
2.5. ANALYSES AND STATISTICS 
2.5.1. STUDY I 
A convenient sample of subjects was recruited for the study. Conditioned pain 
modulation effect was calculated as the difference between the pain intensity rating 
for the test stimuli with and without conditioning stimulus. The terminology used was 
that positive values indicated a CPM effect (i.e. a CPM responder) and negative values 
indicated no CPM effect (i.e. a CPM non-responder). The paired-samples t-test was 
used to evaluate the statistical significance of the CPM effect. As a measure of relative 
reliability, intra-class correlation coefficients (ICC) (ICC2,1 for absolute agreement) 
were calculated, and as a measure of absolute reliability, the standard error of 
measurements (SEM) was calculated. Intra-class correlation coefficients can be 
interpreted as “poor reliability” if <0.4, as “fair reliability” if between 0.4 to 0.59, as 
“good reliability” if between 0.6 to 0.75, and as “excellent reliability” if greater than 
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0.75 (81,185). The standard error of measurement reflects the measurement error. 
Therefore, it can be interpreted as an estimate of the variation if tests were repeated 
without any changes occurring in the subjects (186) (study I). 
2.5.2. STUDY II 
Study II was part of a multicenter study, aiming at developing a bed-side test tool for 
evaluating pain sensitization (Sachau et al. manuscript under review). Therefore, no 
separate sample size calculation was made for study II. Mechanical temporal 
summation was calculated as pain intensity rating from repeated stimuli subtracted 
with the pain intensity rating from the single stimulus. Temporal summation of pain 
represents aspects of pain sensitization (58). The difference in test stimuli pain 
intensity ratings with and without conditioning stimulus reflects the CPM effect. 
Contrary to the terminology used in study I, a positive value indicated a facilitatory 
CPM response and a negative value indicated an inhibitory CPM response. The 
change of terminology was based on the recommendations from Yarnitsky et al., 
(187). Patients with signs of facilitated CPM were referred to as non-responders and 
patients with signs of inhibitory CPM were referred to as responders. Lack of 
inhibitory CPM represents aspects of impaired central pain inhibition (58). 
Evaluation of normal distribution of data was made by assessing histograms, QQ-
plots, and Shapiro-Wilk tests. There was a significant difference in BMI between the 
OA and the TKA group, why an ANCOVA test adjusting for BMI was conducted for 
the continuous outcomes. Analysis of associations between the physical 
performances, in other words, the 30-second chair stand test, the 40-meter fast-paced 
walk test, and the stair climb test (dependent variables) and pain intensity, mechanical 
pinprick pain sensitivity, temporal summation, CPM, and the KOOS subscales ADL 
and sports and recreational activities (independent variables) were conducted in each 
group separately. The analysis was conducted by applying multivariate linear 
regression models, using the enter method with an adjustment for age, sex, and BMI. 
The calculated β-coefficients suggest how strongly the independent variables 
influenced the dependent variables. The R2 value is an indication of the ratio of 
variability explained by the independent variable or the adjusted regression model. 
Based on the explorative design of the study, exact p-values and effect sizes are 
reported to enhance interpretation and discussion of the between-group differences. 
Effect sizes were calculated as Hedges ´g and interpreted as < 0.2 = “very small,” 0.2 
= “small,” 0.5 = “medium,” 0.8 = “large,” 1.2 = “very large,” and 2.0 = “huge” as 
provided by Sawilowsky (188) and Cohen (189) (study II). 
2.5.3. STUDY III 
For the primary outcome KOOS, an improvement of 8-10 points from baseline to re-
test has been proposed as a minimal clinically important difference (MCID) (190). 
Data was evaluated for normal distribution using histograms, QQ-plots, and the 
CHAPTER 2. METHODS 
24 
Shapiro-Wilk tests, and paired samples t-tests were applied for normal distributed and 
continuous outcomes. Non-normal distributed outcomes were analyzed using the 
Wilcoxon signed-rank test. To enhance interpretation, effect sizes were calculated as 
Cohen's d = (Mean2 - Mean1) ⁄ SDpooled. Interpretation of effect sizes followed the 
suggestion by Cohen (189); 0.2 = “small,” 0.5 = “medium” and 0.8 = “large” (study 
III). 
2.5.4. STUDY IV 
A sample size calculation was conducted using a difference of 10 points in the KOOS4 
as an MCID (190). The sample size calculation showed that to achieve a study power 
of 90% to detect an improvement of at least 10 points between groups for the KOOS4, 
49 patients would be required in each group. To account for possible dropouts and 
missing data, 60 patients will be included in each group. The intention-to-treat 
principle will be used for the statistical analysis regarding the primary outcome. Data 
is expected to be normally distributed and, therefore, data analysis will use a repeated 
measure mixed model with patients as random effect and time (i.e. baseline, 3, 6, and 
12 months) and treatment (i.e. neuromuscular exercises and PNE or PNE alone) as 
fixed effects. Secondary outcomes will be analyzed in a similar way to the primary 
outcome. A per-protocol analysis will be made for the primary outcome in which 
patients with poor adherence to the interventions will be excluded. Poor adherence 
will be defined as attending less than 75% of the exercise sessions and not attending 
both PNE sessions. Similarly, a per-protocol analysis will exclude patients who 
receive additional surgery in their index knee during the follow-up period (study IV). 
The ongoing RCT will include 120 patients of which 60 patients will be allocated to 
receive neuromuscular exercises and PNE, and the other 60 patients will receive PNE 
alone. The flow diagram (Figure 8) illustrates the status of recruitment (as of 
05.01.2021). Due to the difficulty in recruiting patients and the COVID-19 pandemic, 
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Figure 8: Flow chart for patient recruitment in the ongoing randomized controlled 
trial. 
 
For all studies, the significance level was set to P<0.05. All analyses were made using 




CHAPTER 3. RESULTS 
3.1. STUDY I: 
Characteristics of the study populations are presented in Table 3.  
Table 3: Characteristics for study I populations.  
 Test-retest part  
(n= 22) 
Methodological part  
(n= 29) 
Age (mean ± SD) 23.6 (±2.4) 21.5 (±1.6) 
Sex (males, %) 15 (68%) 9 (31%) 
Dominant leg side* 
(right, %) 
18 (82%) 26 (90%) 
* Leg side was determined by asking the question “which leg would you use to kick a football.” 
Adapted from study I. 
 
Averaged conditioned pain modulation effect 
 
Conditioned pain modulation effects are shown in Table 4. It can be seen that none of 
the test protocols elicited significant averaged CPM effects. The number of subjects 
classified as having an inhibitory CPM effect (i.e. a CPM responder) varied between 
study cohorts and within test protocols (see Figure 1 in thesis at a glance). Conditioned 
pain modulation responder rates were nine (40%), 10 (45%), 13 (45%), 11 (38%), and 
12 (41%) for test protocol 1 (session 1 and 2), test protocol 2, test protocol 3, and test 
protocol 4, respectively. 
Table 4: Conditioned pain modulation (CPM) effect in study I. Positive values 
indicate a CPM effect. 
 Conditioned pain modulation effect 
(95% CI) 
NRS (test protocol 1 – session 1) § 0.3 ns 
(-0.37 ; 1.01) 
NRS (test protocol 1 – session 2) § 0.2 ns 
(-0.20 ; 0.66) 
VAS (test protocol 2) ^ 0.2 ns 
(-0.17 ; 0.55) 
VAS (test protocol 3) ^ - 0.1 ns 
(-0.55 ; 0.28) 
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VAS (test protocol 4) ^ 0.0 ns 
(-0.45 ; 0.45) 
NRS: Numerical rating scale. VAS: Visual analog scale. ns: Non-significant. CI: Confidence 
intervals. §: Study cohort for the test-retest part. ^: Study cohort for the methodological part. 
The mean (±SD) conditioning stimulus pain intensities for test protocol 1 (session 1 
and 2), 2, 3, and 4 were 4.4 (±1.7), 3.9 (±1.7), 2.9 (±1.8), 2.2 (±1.7), and 2.4 (±1.6), 
respectively. 
Reliability measures 
Table 5 shows the reliability outcomes for both relative (ICC) and absolute reliability 
(SEM) for the test stimuli with and without conditioning stimulus. Significant 
correlations for measurements both with and without conditioning stimulus were 
observed (ICC model2.1 for absolute agreement, P: <0.000 and <0.000, respectively). 
The ICC coefficients were interpreted as “good” relative reliability.  
Table 5: Test-retest measures of relative and absolute reliability 






Test stimulus without 
conditioning stimulus 
(session 1 vs. session 2) 
0.67* 
(0.36 ; 0.85) 
1.9 
 
Test stimulus with 
conditioning stimulus 
(session 1 vs. session 2) 
0.72* 
(0.44 ; 0.87) 
2.1 
ICC: Intra-class correlation coefficient. SEM: Standard error of measurement.  
NRS: Numerical rating scale.*: p-value < 0.000. Adapted from study I. 
Additional outcome measures can be found in the original manuscript (study I). 
3.2. STUDY II 
Patient demographics for both OA and TKA patients are shown in Table 6.  
Table 6:  Patient characteristics for the population in study II. Values are mean (SD) 
unless otherwise stated. 
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 Osteoarthritis patients 
(n: 46) 
Total knee arthroplasty 
patients 
(n: 24) 
Age (years) 66.4 (8.2) 66.5 (7.2) 
BMI (kg/m2) 28.0 (3.7) 30.8 (4.5)* 
Sex (males, %) 27 (59%) 9 (37 %) 
Time since knee OA 
diagnosis (years) § 
11.1 (7.6) NA 
Time since surgery (years) ^ NA 4.0 (1.9) 
BMI: Body Mass Index. NA: Not applicable. * p-value = 0.007 between groups. § Time since 
osteoarthritis diagnosis is the period from being diagnosed with knee osteoarthritis to the day 
of the test. ^ Time since surgery is the period from the day of total knee arthroplasty surgery to 
the day of the test. Adapted from study II. 
Pain intensity and pain sensitization 
The BMI adjusted outcomes for pain and quantitative sensory profiling are listed in 
Table 7. 
No between-group differences were observed for the adjusted pain and pain 
sensitization outcomes. Consequently, effects sizes were interpreted as “very small” 
for pain intensity (0.06), localized temporal summation (0.00), extra-segmental 
temporal summation (0.09), and CPM (0.15), and as “small” for localized (0.23) and 
extra-segmental (0.29) mechanical pinprick pain sensitivity. 
Table 7: Results from pain intensity and quantitative sensory profiling. Estimates are 


























































(-0.55 to 0.57) 
0.974 
Conditioned pain 






(-0.76 to 0.61) 
0.828 
SE: Standard error. NRS: Numerical rating scale. VAS: Visual analog scale. CI: Confidence 
interval. § Positive values indicate facilitatory conditioned pain modulation. Adapted from 
study II. 
No significant averaged CPM effect was observed in either group (P= 0.084 and 
0.851, for the OA and the TKA groups respectively). The VAS pain intensity of the 
conditioning stimulus was 6.7 (±2.6) in the knee OA group and 5.4 (±2.3) in the TKA 
group. When CPM was analyzed and ranked for each individual, a distribution with 
both facilitatory and inhibitory CPM responses was observed (see Figure 1 in thesis 
at a glance). 
Physical performances 
It was observed that the OA group performed consistently better compared to the TKA 
group for the 30-second chair stand test (P= 0.015), the 40-meter fast-paced walk test 
(P= 0.081), and the stair-climb test (P= 0.002) (Figure 9). Effect sizes were interpreted 
as “medium” for the 30-second chair stand test (0.74) and the 40-meter fast-paced 
walk test (0.64) and as “large” for the stair climb test (0.98). 
Figure 9: Outcomes, adjusted for body mass index, for the physical performances for 




Exact values are listed for each outcome. Adjusted means are presented with standard error. 
Reps: Repetitions. Sec: Seconds. 
Patient-reported outcome measures 
For the KOOS subscale sports and recreational activities, a significant difference was 
observed with the OA group reporting the best outcome (Table 8). For the KOOS 
subscales pain, symptoms, ADL and knee-related QOL, and minor and non-
significant between-group differences were detected. Effects sizes were interpreted as 
“small” for the subscales pain (0.21), symptoms (0.41), ADL (0.21), and knee-related 
QOL (0.31) and as “medium” for the subscale sports and recreational activities (0.73) 
Table 8: Outcomes for the KOOS subscales. Estimates are adjusted for BMI and 











KOOS pain 59.2 (2.5) 57.2 (3.5) 2.0 
(-6.8 to 10.7) 
0.653 
KOOS symptoms 53.6 (2.2) 49.7 (3.0) 3.9 
(-3.7 to 11.5) 
0.311 
KOOS ADL 61.9 (2.2) 61.4 (3.1) 0.5 
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KOOS sports and 
recreational 
activities  
26.3 (2.8) 12.2 (3.9) 14.1 
(4.3 to 23.8) 
0.005 
KOOS knee-related 
quality of life 
39.7 (2.3) 34.9 (3.2) 5.6 
(-2.5 to 13.6) 
0.171 
KOOS: Knee injury and Osteoarthritis Outcome Score. SE: Standard error. BMI: Body mass 
index. ADL: Activities of daily living. Adapted from study II. 
Associations for the osteoarthritis group 
The KOOS sports and recreational activities and facilitatory CPM were significantly 
(p= 0.032 and p= 0.043, respectively) associated with the 30-second chair stand test 
(R2 change: 0.094 and 0.088, respectively). Localized temporal summation was 
significantly (p= 0.031) associated with the 40-meter fast-paced walk test (R2: 0.081). 
Localized temporal summation and facilitatory CPM were significantly (p= 0.007 and 
p= 0.029, respectively) associated with the stair climb test (R2: 0.108 and 0.072, 
respectively). Estimates for the non-significant independent variables are presented in 
Table 3 of the study II manuscript. 
Associations for the total knee arthroplasty group  
The independent variables localized and extra-segmentally mechanical pinprick pain 
sensitivity were significantly (p= 0.035 and 0.017, respectively) associated with the 
30-second chair stand test (R2: 0.169 and 0.137). The independent variables KOOS 
ADL and sports and recreational activities were significantly (p= 0.012 and p= 0.026, 
respectively) associated with the 40-meter fast-paced walk test (R2: 0.210 and 0.172, 
respectively). The independent variables KOOS ADL and sports and recreational 
activities were significantly (p= 0.017 and p= 0.001, respectively) associated with the 
stair climb test (R2: 0.159 and 0.253, respectively). Estimates for the non-significant 
independent variables are presented in Table 4 of the study II manuscript. 
3.3. STUDY III 
Patient characteristics are shown in Table 9. 
Table 9: Patient characteristics for the study III population. Values are mean (SD) 
unless otherwise stated. 
 Primary total knee 
arthroplasty 
(n: 166) 
Revision total knee 
arthroplasty 
(n: 51) 
Age (years) 64.0 (8.6) 62.2 (8.8) 
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BMI (kg/m2) 28.9 (4.3) 28.3 (5.0) 
Sex (males, %) 52 (31) 21 (41%) 
Index leg (right, %) 87 (52 %) 30 (59 %) 
Time-since-surgery 
(months)* 
3.7 (5.9) 2.7 (2.4) 
BMI: Body Mass Index. * Time-since-surgery: The period from the day of surgery (primary or 
revision total knee arthroplasty) to the date of hospitalization. Adapted from study III.  
Significant improvements for the primary outcome KOOS were observed for both 
groups (Figure 10). For the primary TKA group, improvements ranged from 9.8 (95% 
CI 7.6 to 12.0, p< 0.000), 9.4 (95% CI 7.3 to 11.5, p< 0.000), 14.2 (95% CI 12.2 to 
16.2, p< 0.000) and 8.5 (95% CI 6.1 to 10.9, p< 0.000) for the KOOS subscales pain, 
symptoms, ADL and knee-related QOL. For the revision TKA group, improvements 
ranged from 6.9 (95% CI 2.2 to 11.7, p= 0.005), 8.2 (95% CI 4.0 to 12.4, p< 0.000), 
10.8 (95% CI 6.8 to 14.7, p< 0.000) and 8.6 (95% CI 3.5 to 13.8, p= 0.001) for the 
KOOS subscales pain, symptoms, ADL and knee-related QOL, respectively. 
Figure 10: Knee injury and Osteoarthritis Outcome Score from baseline to post-
rehabilitation for both groups. 
 
KOOS: Knee injury and Osteoarthritis Outcome Score. ADL: Activities of daily living. QOL: 
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Effect sizes for the primary TKA group were interpreted as “medium” for KOOS pain 
(0.57), KOOS symptoms (0.58), and KOOS knee-related QOL (0.51) and as “large” 
KOOS ADL (0.88). For the revision TKA group, effects were interpreted as “small” 
for the KOOS pain (0.38) and KOOS knee-related QOL (0.46) and as “medium” for 
KOOS symptoms (0.54) and KOOS ADL (0.70). 
The results for pain intensity during activity, the 6 min. walking test and the stair 
climb test for both groups can be seen in Table 9. All secondary outcomes improved 
significantly and effect sizes were interpreted as “medium” for pain intensity during 
activity (0.62) and the stair-climbing test (0.77) and as “large” for the 6 min. walking 
test (0.96) for the primary TKA group and as “small” for the pain intensity during 
activity and as “large” for the 6 min. walking test (0.81) and the stair climb test (0.82) 
for the revision TKA group. Additional outcome measures can be retrieved in the 
original manuscript (study III). 
Table 9: Secondary outcomes for both groups in study III. Values are mean (SD) 
unless otherwise stated. 
 Primary total knee arthroplasty 
(n: 166) 

































































CHAPTER 4. DISCUSSION 
In this section, the presented results are compared and discussed, both within the study 
I – IV and related to existing evidence from the literature. Possible mechanisms 
underlying the effect of exercise and the interaction between the multiple factors 
behind chronic pain and the significance thereof is addressed. The strengths and 
limitations of the specific studies and the overall thesis are discussed. Lastly, a 
conclusion based on the main findings from study I – IV is presented in combination 
with the relevant implications and perspective.  
4.1. SUMMARY OF MAIN FINDINGS 
The overall aim of the thesis was to examine pain outcomes, pain sensitization, CPM, 
patient-reported outcomes, and physical performances in patients with chronic pain 
after knee OA or TKA, by using quantitative pain assessment and evaluating 
outcomes following conservative interventions. Study I sought to develop a clinically 
applicable method to examine CPM. The results indicated “good” relative reliability 
(81,185) of the test stimuli, though the absolute reliability indicated substantial 
individual variation. No averaged CPM effect was observed in the healthy subjects, 
and in the population, a substantial variation in the CPM effect was observed in CPM 
responders and non-responders. Study II aimed at profiling and comparing outcomes 
regarding pain intensity, pain sensitization, CPM, patient-reported outcomes, and 
physical performances in populations with chronic knee OA pain and chronic pain 
following TKA. The results indicated that similar profiles for pain intensity, pain 
sensitization, CPM, and patient-reported outcomes were observed for the OA and the 
TKA population. Contrary to these findings, differences in physical performances 
were observed, with the OA group consistently performing better physically. As in 
study I, no averaged CPM effect was observed and a substantial variation in the CPM 
effect was seen, including both CPM responders and non-responders in the OA and 
the TKA groups. Study III investigated the effects of intensive, multimodal 
rehabilitation in a population of patients with post-surgical complications following 
primary or revision TKA. The results showed improvements in pain intensity, patient-
reported outcomes and physical performances following three weeks of intensive, 
multimodal rehabilitation. Based on the lack of evidence regarding the management 
of chronic pain after TKA, study IV was initiated. This ongoing randomized 
controlled trial investigates the effect of exercise and PNE in a population of patients 
with chronic pain after TKA. 
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4.2. CHRONIC PAIN AND PAIN SENSITIZATION IN PATIENTS 
WITH KNEE OSTEOARTHRITIS AND TOTAL KNEE 
ARTHROPLASTY 
By definition, pain is termed as chronic when it lasts for at least three months (55). In 
study II and study IV, the inclusion criteria of at least six months of pain was used, 
and for study IV, patients have to be at least 12 months post-operative (study II and 
IV). These criteria were applied to ensure that patients experienced chronic pain and 
features of pain sensitization and that no spontaneous recovery following the TKA 
procedure could be expected. This was based on findings that suggested that the 
duration of pain can be associated with increased pain sensitization (93) and that 
outcomes after TKA could improve for up to 6-12 months post-operatively (191,192). 
Pain sensitization has been proposed as an important mechanism behind chronic pain 
(66,67,171). However, since pain sensitization can be measured only as a proxy and 
not directly (70,71,74), it is difficult to accurately conclude whether a patient is 
sensitized. Typically, heightened pain responses to painful stimuli (i.e. hyperalgesia), 
pain responses from non-noxious stimuli (i.e. allodynia), increased pain response from 
accumulated stimuli of equal intensity (i.e. temporal summation of pain), and the 
presence of widespread pain are interpreted as indications of pain sensitization 
(67,71,73-75). Especially, temporal summation of pain has been referred to as a 
symptom of a central pain mechanism, which indicates the presence of pain 
sensitization (58,71,167). Evaluation of pain sensitization outcomes has been 
proposed as a continuum of signs of pain sensitization more than the presence of or 
no presence of pain sensitization (71,171)). 
Traditionally, somatosensory parameters have been examined using the QST protocol 
from the German Research Network on Neuropathic Pain (95,96), but more recently, 
studies have attempted to develop and evaluate possible bed-side methods to 
investigate pain sensitization that is not too time-consuming or requires expensive 
equipment ((99,193). Such bed-side methods are used in study II and IV and provide 
information on hyperalgesia, allodynia, and temporal summation of pain, which are 
mechanisms believed to indicate pain sensitization (99,193). Pain sensitization is 
thought to be driven and/or maintained by peripheral, nociceptive inputs 
(71,74,194,195). Studies demonstrate that elimination of the peripheral, nociceptive 
input can diminish pain sensitization (71,155,196,197). These observations indicate 
that pain sensitization could be reversed when the peripheral nociceptive inputs were 
removed, for example, following successful joint replacement surgery. It remains 
unknown why some patients suffering from long-lasting chronic pain (e.g. from knee 
OA) experience chronic pain after TKA and show signs of pain sensitization, whereas 
others will experience pain relief following TKA. The results and analysis from study 
IV will allow for an evaluation of how pain sensitization will change during the 
intervention period and the subsequent follow-up period. Such analysis could reveal 
whether improvements in pain intensity, patient-reported outcomes, and physical 
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performances can be achieved with or without changes in pain sensitization, which 
will allow to evaluate the impact of pain sensitization on these parameters.  
4.3. CONDITIONED PAIN MODULATION  
Study I aimed to develop an easy-to-use CPM method that could be applied in clinical 
settings. In the population of healthy subjects, no averaged CPM effect was observed. 
Instead, a substantial variation in CPM responders and non-responders were observed. 
In general, a CPM effect can be elicited in healthy subjects and impaired CPM can be 
observed in populations with chronic pain (81,83,85). However, several studies have 
observed substantial variation in CPM effects (84,86,87,89,90,198-201). It has been 
shown that the individual CPM effect is influenced by age (77,83,85,202), sex (83-
85,201), test sites (199), type of test stimulus (198,203), and type of conditioning 
stimulus (198-200). To date, no specific CPM test paradigm can be identified as 
superior to other CPM test paradigms (80,89,187) and different types of test and/or 
conditioning stimuli can elicit different CPM responses in the same individual (198-
200,203).  
Klyne et al. (204) found that using PPT as a test stimulus was more valid for observing 
CPM effects compared to using pain responses as a test stimulus. In studies I and II, 
a pain response from the pressure algometer test stimulus was used to evaluate the 
CPM effect. Therefore, the lack of observed CPM effect in the healthy subjects in 
study I could have been influenced by the pressure pain response as a test stimulus 
and the CPM effects might have been different if measured using PPT. In study I, an 
ICC of 0.67 for test stimulus without conditioning stimulus and 0.72 for test stimulus 
with conditioning stimulus indicated that “good” relative reliability was achieved 
(81,185). Contrary to the relative reliability, the SEM values of 1.9 for test stimulus 
without conditioning stimulus and of 2.1 for test stimulus with conditioning stimulus 
indicated that absolute reliability was somewhat low, which was illustrated by a 
substantial individual variation in the CPM effect. Most CPM reliability studies focus 
on the relative reliability and, in general, these studies observe good-to-excellent 
relative reliability (81,101,198). Absolute reliability (e.g. SEM) is a measure of the 
measurement error of the observations and has, therefore, been suggested as a method 
to indicate whether a “true” CPM effect has been elicited (205). As observed in study 
I and II, substantial individual variations in the CPM effect has been detected in other 
studies evaluating absolute reliability (200,205). The substantial individual variations 
have been suggested to illustrate that different pain systems could be activated by 
different combinations of test and conditioning stimuli (e.g. cutaneous or deeper tissue 
stimulation) (198,200). However, this assumption needs further investigation. 
In study I, both NRS and VAS were used as outcome measures for the pain response 
from the test stimuli. For the test-retest part, an NRS was used to evaluate pain 
intensity as it is frequently used in clinical settings and is an easy method to implement 
(97). In the methodological part, a VAS was used to evaluate pain intensity. The 
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method was changed since it was considered a possible bias that subjects were able to 
recall the exact first pain rating (without conditioning stimulus) when evaluating the 
second pain rating (with conditioning stimulus). Therefore, using a VAS slider was 
considered less prone to bias. The VAS and NRS have been observed to generate very 
similar pain intensities when used simultaneously (206). Therefore, the VAS was used 
to measure the pain intensity responses in study II. 
Study II observed no significant, averaged CPM effect in the population with chronic 
pain because of knee OA or after TKA, which is in line with findings from other 
chronic pain populations (81,90,207). As seen in study I, a substantial variation 
between CPM responders, non-responders, and patients with no change in pain 
responses was observed. This implies that it might not provide sufficient information 
to only evaluate averaged CPM effects, but is important to evaluate individual CPM 
data to gain insight on individual variation. A recent CPM study demonstrated that 
approximately half of the included population of healthy subjects showed no signs of 
CPM effect (i.e. a non-responder) and that the CPM effect, measured as a change in 
pain intensity ratings, varied from -100% (pain inhibition, i.e. responder) to +112.5% 
(pain facilitation, i.e. non-responder) (201). Other studies observing substantial 
individual variations in CPM effect in healthy subjects, and which, therefore, include 
responders and non-responders, have proposed that averaged group-level CPM 
analysis may not be appropriate (89,103). Based on the novel observations from 
studies I and II as well as findings in recent CPM studies (89,103,201), it is 
recommended that future CPM studies should focus on individual information 
regarding CPM effect and responder or non-responder classification. However, how 
to truly classify individuals as responders or non-responders remains debatable and 
several suggestions have been made to determine a “true” CPM effect, allowing 
possible measurement errors to be taken into consideration (89,199,200,205,208). It 
remains to be investigated whether chronic pain patients with differences in CPM 
responses also exhibit different pain trajectories and, therefore, might respond 
differently to treatment interventions. The focus must remain on individual profiling 
of the CPM effect in chronic-pain patients to investigate this in future studies. It is 
expected that the completion of study IV will shed some light on this unclear aspect 
of pain modulation. 
4.4. ASSOCIATIONS FOR PATIENTS WITH KNEE 
OSTEOARTHRITIS AND TOTAL KNEE ARTHROPLASTY 
The explorative findings in study II revealed that signs of pain sensitization (measured 
as mechanical temporal summation) were associated with poorer physical 
performances in the OA group and that patient-reported function (KOOS subscales 
ADL and sports and recreational activities) were associated with physical 
performances in the TKA group (study II). While these findings should be considered 
as hypothesis-generating and have limitations (see section 4.8), the differences in 
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associations, despite similar pain profiles, are interesting and should be further 
investigated in studies with adequate statistical power.  
The observed associations between pain sensitization and physical performances in 
the OA group confirm other findings in knee OA (209) and low back pain populations 
(210), although different methods to assess pain sensitization were used. Study II used 
mechanical temporal summation at the index knee as the indication for pain 
sensitization, whereas Guérard et al. used the presence of widespread pain and Echeita 
et al. used the questionnaire Central Sensitization Inventory (209-211). Similar to the 
findings in study II, both Guérard et al. and Echeita et al. observed variation in 
associations for physical performances and pain sensitization ((209,210). This intra-
individual variation, where some pain sensitization outcomes are associated with 
physical performances and others are not, underlines that the exact mechanisms 
behind pain sensitization and the evaluation of physical performances are 
unexplained. It remains to be fully understood why signs of pain sensitization manifest 
differently in various outcomes and why pain sensitization can also be differently 
associated with physical performances. Studies have shown that physical 
performances are influenced by factors such as age, sex, BMI, physical activity levels, 
and pain catastrophizing, which adds further to multifactorial factors underlying these 
associations (35,209,210,212). Moreover, studies have shown that functional 
impairments and muscle weakness are present following knee joint replacement (213-
216), which illustrates that such factors may also influence the pain experience, the 
self-reported function, and the physical performances after TKA. This reflection could 
vindicate that multimodal assessment of key elements (e.g. pain severity and 
intensities, quantitative sensory profiling of pain sensitization and CPM, patient-
reported outcomes, and physical performances) in chronic knee pain patients should 
be undertaken to capture the individual factors of the patient’s situation as a whole. 
Such an approach could potentially form the basis of personalized treatment.  
4.5. PATIENT-REPORTED OUTCOMES IN PATIENTS WITH KNEE 
OSTEOARTHRITIS AND PRIMARY OR REVISION TOTAL 
KNEE ARTHROPLASTY   
The KOOS questionnaire, consisting of the subscales pain, symptoms, ADL, sports 
and recreational activities, and knee-related QOL, revealed similar findings in study 
II and study III (results for pre-rehabilitation). Following the intensive, multimodal 
rehabilitation in study III, an improvement in all KOOS subscales was observed, 
elevating the KOOS scores to the highest values observed in study II and III. The 
KOOS subscale sports and recreational activities, which were included in study II, 
showed the lowest values, indicating that strenuous activities, such as squatting, 
kneeling, and twisting on the knee, impose the most difficulties. The KOOS sports 
and recreational activities subscale was not part of study III since many surgeons 
consider such activities to be contraindicated after TKA. Therefore, this domain was 
omitted during the patient assessment (study III). 
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In study III and IV, the KOOS questionnaire is the primary outcome. In intervention 
studies, it is important to evaluate whether an observed improvement can be 
considered a clinically, meaningful change (217-219). In studies III and IV, an MCID 
of 8-10 points and 10 points, respectively, are used as cut-off values to indicate a 
minimum change that can be regarded as clinically significant (190,220,221). 
However, the establishment of MCID values remains debatable and variations have 
been observed because of different methods to calculate the MCID, different patient 
populations, and differences in follow-up periods (217,219,222,223). Consequently, 
Singh et al. suggested an MCID of 8 points in a study of knee OA patients referred to 
an orthopedic surgeon, who had two weeks follow-up (223), whereas Goodman et al. 
suggested an MCID of 21 points for the KOOS pain subscale and 14 points for the 
KOOS ADL subscale in a population of patients having received TKA two years 
earlier (222). Lastly, Lyman et al., in their population of patients undergoing TKA 
and having two years of follow-up, suggested MCID values of 18 points for the KOOS 
pain subscale, 7 points for the KOOS symptoms subscale, 16 points for the KOOS 
ADL subscale, 17 points for the KOOS sports and recreational activities subscale, and 
14 points for the KOOS knee-related QOL subscale (217). In summary, no universally 
accepted MCID values for the KOOS exists (219). Furthermore, it remains debatable 
whether values such as MCID should be reported at group-level or as percentages of 
individual subjects fulfilling the specified criteria (224). 
4.6. PHYSICAL PERFORMANCES IN PATIENTS WITH KNEE 
OSTEOARTHRITIS AND PRIMARY OR REVISION TOTAL 
KNEE ARTHROPLASTY   
Physical performance outcomes are recommended as measures to monitor the 
progress of treatment modalities in patients with chronic pain (183,225-227). 
Activities of daily living, such as walking, stair climbing, getting in and out of bed, 
and rising from a chair, are functions that are often impaired in patients with chronic 
pain because of knee OA or after TKA (22,25,34,37,39). In study II, significant 
differences for the 30-second chair stand test and the stair-climb test were observed 
between the OA and TKA groups. Similar pain and pain sensitization outcomes 
between the groups indicates that other factors are important for the physical 
performances in patients with chronic pain after TKA. Firstly, it could be explained 
by low levels of physical activity after TKA, which leads to impaired physical 
performances. Studies have shown that patients undergoing TKA failed to adhere to 
the general health recommendations of being physically active, in other words, 
activity of moderate intensity for 30 minutes at least five days per week (228-230). 
No data for physical activity levels were collected in study II and, therefore, this 
assumption cannot be verified. Secondly, chronic pain after TKA could be related to 
pre-operative pain sensitization and higher pre-operative pain intensities as this can 
be associated with poorer outcome following TKA (41,231,232). It has been 
suggested that chronic pain after TKA is often a sign of a complex manifestation of 
pain mechanisms (75), which could affect the physical performances in this patient 
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population. No pre-operative observations were available for the TKA population to 
assess these associations. Lastly, psychological traits such as pain catastrophizing, 
fear-avoidance, and anxiety are known to influence chronic pain and physical 
performances (43-48) and could, therefore, have influenced the results. Since 
outcomes for psychological parameters were not evaluated in study II, this assumption 
cannot be investigated. Study IV includes outcomes such as pain catastrophizing and 
fear-avoidance beliefs and will be able to examine the association between these 
psychological traits and physical performances.  
4.7. EXERCISE AND PAIN NEUROSCIENCE EDUCATION AS 
TREATMENT IN PATIENTS WITH PRIMARY OR REVISION 
TOTAL KNEE ARTHROPLASTY  
Study III evaluated an intensive, multimodal rehabilitation regimen, which provided 
novel insight into the benefits of exercise in a population of patients with 
complications following a TKA surgery. In general, exercise is recommended as a 
treatment for chronic pain (65,105,117,120,131,233). Exercise is also recommended 
following TKA to regain the ability to engage in activities of daily living and to 
optimize physical performances, although variation is observed in effect sizes and the 
long-term effect (140,192,213,216,234,235). Furthermore, studies are often 
undertaken in the early post-operative phase and not during later stages when chronic 
pain might have developed (213,234). Consequently, no RCT has evaluated whether 
exercise is an effective treatment modality for patients with chronic pain after TKA, 
thus explaining why an RCT was initiated (study IV).  
Study III analyzed the clinical data of patients experiencing post-surgical 
complications after primary or revision TKA and observed medium-to-large effect 
sizes for both patient-reported and physical performance outcomes (study III). Despite 
being a retrospective, non-controlled study, the results indicate that it could beneficial 
to use exercise for patients with chronic pain following TKA, and it warrants further 
validation of this observation. Therefore, study IV was initiated to evaluate whether 
exercise remains a viable treatment option in an RCT. Contrary to the multimodal 
treatment approach used in study III, study IV uses the NEMEX-TJR program (study 
IV). Because of the mixture of exercise treatments (e.g. neuromuscular exercises, 
flexibility exercises, re-training of gait patterns, resistance training, and 
cardiovascular training) in study III, it cannot be established which type of exercises 
are the most beneficial or if the combination of exercise types provides additional 
benefit. Overall, no specific type of exercise has demonstrated superiority to others 
when evaluating the effect in populations with OA pain (106,117,236,237), 
musculoskeletal pain (65,120), or rehabilitation following TKA (216,235). Therefore, 
it appears that exercise, regardless of type and mode, is beneficial for treating chronic 
pain in various conditions (65,106,117,120,131,192,216,235-237). Likewise, the 
optimal intensity, dosage, and frequency of exercise have not been established either 
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(65,106,117,120,236,238) and are frequently mentioned as important research areas 
for future investigations (65,106,120,192,216,238). 
Several mechanisms behind the beneficial effects of exercise have been suggested 
(see section 1.4.2 and 1.4.4). Studies have attempted to predict the effect of 
physiotherapy treatment (167) or examine associations between pain mechanisms and 
outcomes following TKA (50), neuromuscular exercises (239), and pharmacological 
treatment (240). No measures of, for example, pain sensitization or pain 
catastrophizing were retrieved in study III, which could have assisted in interpreting 
the mechanisms behind the improvements. Such outcomes are included in study IV 
and will, in time, determine which pain mechanisms can be modulated by 
neuromuscular exercises and PNE. In study IV, PNE is introduced to patients to re-
conceptualize their understanding of their chronic pain (146,147,149,153), which has 
been shown to decrease pain catastrophizing and kinesiophobia (146,147,151,152). In 
a recent viewpoint paper, Louw et al. (241) argue that PNE alone would only have a 
minimal effect on chronic pain. It was argued that exercise and movement should be 
the focus of the treatment interventions and that PNE should be used in conjunction 
with exercise (241). Other studies have pointed out that PNE in conjunction with 
exercise appears to provide superior results compared to exercise or PNE alone 
(149,152). Since PNE has not been evaluated as a treatment for chronic post-operative 
pain, but only as a pre-operative approach, it remains to be seen whether this treatment 
modality is effective in patients with chronic pain after TKA.   
4.8. STRENGTH AND LIMITATIONS 
Several limitations from the studies should be acknowledged. For the CPM methods 
introduced in study I and II, no control condition was used. Therefore, the changes in 
pain ratings could reflect random variation and not facilitatory or inhibitory CPM 
responses. Study I and II use different terminology when referring to the CPM effect, 
which could confuse interpretation, although both studies clearly state how the CPM 
effect, responders, and non-responders are defined (study I and II). Study II was an 
explorative, cross-sectional study in which causal effects cannot be investigated. 
Study II was not powered to detect and establish associations and, therefore, these 
results should be evaluated as hypothesis-generating more than as conclusive (study 
II). However, the inclusion of pain intensity, pain sensitization, CPM, patient-reported 
outcomes, and physical performances should be considered a strength, which 
facilitated the evaluation of physical performances in the context of chronic pain 
patients. Psychological traits have been shown to interfere with chronic pain and this 
could have influenced the findings in studies II and III. Study IV does include such 
psychological measures and these results will be able to account for these possible 
influencing factors. Due to the observational nature of study III, no control group was 
included, and the study cannot evaluate the effect of time on the results. Likewise, no 
long-term follow-up is available after the discharge and, therefore, it is not known 
whether the benefits from intensive, multimodal rehabilitation will persist over time. 
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However, the structure and practicalities in study III reflect the real-world practice 
and the findings could be regarded as indications of effectiveness. The overall 
strengths of study IV are the inclusion of multiple outcomes, for example, pain 
intensity, pain sensitization, CPM, patient-reported outcomes, physical performances, 
and muscle strength in a randomized trial. These future novel findings will provide 
insight into the mechanisms behind chronic pain after TKA, what treatment effect 
from exercise and PNE can be expected in this population, and whether long-term 




CHAPTER 5. CONCLUSION 
This PhD thesis addressed issues related to chronic pain, pain sensitization CPM, 
patient-reported outcomes, and physical performances in patients with chronic pain 
after knee OA or after TKA. Study I developed a clinically applicable method to 
examine CPM. The novel method showed good relative reliability but somewhat low 
absolute reliability. No group-level CPM effect was observed in the population of 
healthy subjects, and a substantial variation in the CPM effect for the individuals was 
registered, which consisted of CPM responders and non-responders. In study II, the 
profiling and comparison of pain intensity, pain sensitization, CPM, and patient-
reported outcomes exhibited similar between-group outcomes in the knee OA and 
TKA populations with chronic pain. However, there were between-group differences 
regarding the physical performances, with the knee OA group illustrating the best 
physical performances. The CPM effect findings illustrated substantial variation in 
the populations of CPM responders and non-responders. Study III found that 
intensive, multimodal rehabilitation resulted in improvements in pain intensity, the 
KOOS questionnaire, and the physical performances of the 6 min. walking test and 
the stair-climbing test. Based on the limited evidence regarding the management of 
chronic pain after TKA, study IV was initiated. This ongoing randomized controlled 
trial investigates the effect of exercise and PNE in a population of patients with 
chronic pain after TKA. In summary, chronic pain reported by patients suffering from 
knee OA or following TKA impacts pain sensitization, CPM, patient-reported 
outcomes, and physical performances to different extents. Overall, substantial 
individual variations were observed for the investigated outcomes, which may 
indicate the heterogeneity of the chronic pain populations underlined by the unclear 
etiology and pathogenesis of chronic pain in these patients. The findings in this thesis 
have limitations based on the cross-sectional nature of studies I and II and the 
retrospective, non-controlled design of study III. Therefore, no causal effects can be 
drawn and results should be interpreted with caution. Study IV will remediate some 
of these limitations because of the randomized controlled trial study design.  
5.1. PERSPECTIVES  
Over the last decade, research into pain mechanisms behind chronic pain has 
intensified. Despite the many efforts to investigate these mechanisms, there is no clear 
understanding of the neurophysiology underlying chronic pain or of the effectiveness 
of interventions in treating the patient’s chronic pain. Well-powered and controlled 
trials are needed to move this research area forward, and the results from the ongoing 
RCT (study IV) will provide novel knowledge regarding the possible effects of 
exercise and PNE. Bed-side testing and the use of clinically applicable tools for 
assessing pain sensitization and CPM are a research area that has recently received 
attention (99,103,193). The development and use of clinically applicable tools to 
examine pain mechanisms in patients with chronic pain will facilitate individual 
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profiling, which could form the base for personalized medicine. Based on the 
substantial individual variation of pain, pain sensitization, patient-reported outcomes, 
and physical performances in populations with chronic pain because of knee OA or 
after TKA, individualized treatment could be an effective way of targeting specific 
pain mechanisms and deficits in individual patients.  
Based on the findings in this thesis, some perspectives for the clinical implications 
can be made. Firstly, when undertaking future CPM studies, authors should report 
individual CPM effects and observations of CPM responders and non-responders. 
Such an approach would allow for separate analysis of what impact the presence or 
non-presence of a CPM effect could have instead of making interpretations on group-
level. Secondly, it is proposed to ensure that a thorough assessment of pain intensity, 
pain sensitization, patient-reported outcomes, and physical performances are 
undertaken for patients with chronic pain because of knee OA or after TKA. This 
would facilitate evaluating the parameters that require attention in the management of 
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